Infectious disease
MONDO:0005550A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent in humans. It can be transmitted by direct or indirect contact.
Also known as: communicable disease, infection, infectious, infectious disease, infectious diseases and manifestations, infectious disorder, transmissible disease, clinical infection
8231 clinical trials for this condition and its sub-types, 298 tagged with Infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Infectious disease
-
Viral infectious disease 134 trials · 4,447 incl. sub-types
42 sub-types
- Primary viral infectious disease 0 trials · 4,252 incl. sub-types Sub-types →
- Viral respiratory tract infection 47 trials · 566 incl. sub-types Sub-types →
- Coronavinae infectious disease 136 trials
- Disease arising from reactivation of latent virus 4 trials · 89 incl. sub-types Sub-types →
- Viral infection of central nervous system 3 trials · 58 incl. sub-types Sub-types →
- Viral hemorrhagic fever 10 trials · 51 incl. sub-types Sub-types →
- Arbovirus fever 0 trials · 46 incl. sub-types Sub-types →
- Kaposi's sarcoma 45 trials Sub-types →
- Human T-lymphotropic virus 1 infectious disease 5 trials · 34 incl. sub-types Sub-types →
- Rabies 27 trials
- Common wart 26 trials
- Vaccinia 17 trials
- Virus-associated trichodysplasia spinulosa 10 trials
- Immunodeficiency 32B 9 trials
- Arbovirus infection 8 trials
- Viral eye infection 0 trials · 8 incl. sub-types Sub-types →
- COVID-19–associated multisystem inflammatory syndrome in children 7 trials
- Human infection by orthopoxvirus 5 trials
- Herpangina 3 trials
- Milker's nodule 3 trials
- Human betaherpesvirus 5 infectious disease 2 trials
- Parvoviridae infectious disease 1 trial Sub-types →
- Zika virus congenital syndrome 1 trial
- Molluscum contagiosum 1 trial
- Pharyngoconjunctival fever 1 trial
- Newcastle disease 0 trials
- Reoviridae infectious disease 0 trials
- Whitewater Arroyo hemorrhagic fever 0 trials
- Congenital Epstein-Barr virus infection 0 trials
- Congenital varicella syndrome 0 trials
- Contagious pustular dermatitis 0 trials
- Epidemic pleurodynia 0 trials
- Exanthema subitum 0 trials
- Focal epithelial hyperplasia 0 trials
- Infective dermatitis associated with HTLV-1 0 trials
- Lumpy skin disease 0 trials
- Neurolymphomatosis 0 trials
- Pseudorabies 0 trials
- Viral esophagitis 0 trials
- Viral gastritis 0 trials Sub-types →
- Viral labyrinthitis 0 trials
- Viral myositis 0 trials
-
Bacterial infectious disease 96 trials · 2,079 incl. sub-types
52 sub-types
- Primary bacterial infectious disease 0 trials · 593 incl. sub-types Sub-types →
- Mycobacterial infectious disease 23 trials · 361 incl. sub-types Sub-types →
- Gram-negative bacterial infections 33 trials · 301 incl. sub-types Sub-types →
- Commensal bacterial infectious disease 0 trials · 273 incl. sub-types Sub-types →
- Gram-positive bacterial infections 7 trials · 253 incl. sub-types Sub-types →
- Pulpitis 191 trials
- Bacterial sexually transmitted disease 8 trials · 114 incl. sub-types Sub-types →
- Bacterial infectious disease with sepsis 78 trials · 113 incl. sub-types Sub-types →
- Anaerobic bacteria infectious disease 2 trials · 100 incl. sub-types Sub-types →
- Spirochaetales infections 1 trial · 99 incl. sub-types Sub-types →
- Bacterial arthritis 24 trials · 94 incl. sub-types Sub-types →
- Staphylococcal infection 41 trials · 84 incl. sub-types Sub-types →
- Bacterial urinary tract infection 55 trials · 81 incl. sub-types Sub-types →
- Clostridium difficile colitis 69 trials
- Bacterial pneumonia 28 trials · 65 incl. sub-types Sub-types →
- Skin disease caused by bacterial infection 13 trials · 57 incl. sub-types Sub-types →
- Meningococcal infection 47 trials · 55 incl. sub-types Sub-types →
- Bifidobacteriales infectious disease 0 trials · 44 incl. sub-types Sub-types →
- Bacterial meningitis 12 trials · 37 incl. sub-types Sub-types →
- Pseudomonas infection 25 trials · 29 incl. sub-types Sub-types →
- Escherichia coli infection 26 trials Sub-types →
- Vibrio infectious disease 0 trials · 16 incl. sub-types Sub-types →
- Mycoplasmoides infection 7 trials · 15 incl. sub-types Sub-types →
- Bacterial endocarditis 15 trials
- Haemophilus infectious disease 14 trials Sub-types →
- Necrotizing soft tissue infection 13 trials Sub-types →
- Empyema 10 trials · 11 incl. sub-types Sub-types →
- Chorioamnionitis 10 trials
- Klebsiella infectious disease 5 trials · 9 incl. sub-types Sub-types →
- Rickettsiosis 2 trials · 7 incl. sub-types Sub-types →
- Tracheitis 2 trials · 7 incl. sub-types Sub-types →
- Enterococcus infectious disease 1 trial · 4 incl. sub-types Sub-types →
- Yersinia infectious disease 0 trials · 4 incl. sub-types Sub-types →
- Peritonsillar abscess 4 trials
- Bacterial conjunctivitis 3 trials Sub-types →
- Bacterial hemorrhagic fever 0 trials · 3 incl. sub-types Sub-types →
- Bacterial gastritis 2 trials
- Fournier gangrene 2 trials
- Septic peritonitis 2 trials
- Opportunistic bacterial infectious disease 0 trials · 1 incl. sub-types Sub-types →
- Actinobacillus infectious disease 0 trials
- Aeromonas hydrophila infectious disease 0 trials Sub-types →
- Pectobacterium carotovorum infection 0 trials
- Proteus infectious disease 0 trials
- Whipple disease 0 trials
- Bacterial myositis 0 trials Sub-types →
- Botryomycosis 0 trials Sub-types →
- Idiopathic severe pneumococcemia 0 trials
- Noma 0 trials
- Pasteurellosis 0 trials Sub-types →
- Pneumonic pasteurellosis 0 trials
- Rat-bite fever 0 trials Sub-types →
-
Sexually transmitted disease 127 trials · 1,708 incl. sub-types
3 sub-types
- Viral sexually transmitted disease 5 trials · 1,593 incl. sub-types Sub-types →
- Bacterial sexually transmitted disease 8 trials · 114 incl. sub-types Sub-types →
- Trichomonas vaginitis urogenital infection 7 trials Sub-types →
-
Respiratory tract infectious disorder 176 trials · 1,334 incl. sub-types
14 sub-types
- Pneumonia 327 trials · 611 incl. sub-types Sub-types →
- Viral respiratory tract infection 47 trials · 566 incl. sub-types Sub-types →
- Fungal lung infectious disease 6 trials · 57 incl. sub-types Sub-types →
- Pulmonary non-tuberculous mycobacterial infection 48 trials
- Streptococcal sore throat 8 trials
- Pleural tuberculosis 7 trials Sub-types →
- Tracheitis 2 trials · 7 incl. sub-types Sub-types →
- Lung abscess 3 trials
- Pneumonic plague 3 trials
- Tuberculous fibrosis of lung 3 trials
- Laryngeal diphtheria 0 trials
- Laryngeal tuberculosis 0 trials
- Nasopharyngeal diphtheria 0 trials
- Silicotuberculosis 0 trials
-
Digestive system infectious disorder 4 trials · 605 incl. sub-types
22 sub-types
- Viral hepatitis 12 trials · 443 incl. sub-types Sub-types →
- Infectious colitis 0 trials · 69 incl. sub-types Sub-types →
- Intestinal infectious disease 3 trials · 49 incl. sub-types Sub-types →
- Small intestinal bacterial overgrowth 18 trials
- Parasitic intestinal disorder 0 trials · 16 incl. sub-types Sub-types →
- Liver abscess (disease) 4 trials
- Campylobacteriosis 3 trials Sub-types →
- Bacterial gastritis 2 trials
- Gastrointestinal tuberculosis 0 trials · 2 incl. sub-types Sub-types →
- Aeromonas hydrophila intestinal disease 0 trials
- Salmonella gastroenteritis 0 trials
- Whipple disease 0 trials
- Anal verrucous carcinoma 0 trials
- Bacterial esophagitis 0 trials
- Colorectal Kaposi sarcoma 0 trials Sub-types →
- Fungal esophagitis 0 trials Sub-types →
- Fungal gastritis 0 trials
- Internal hirudiniasis 0 trials
- Oropharyngeal anthrax 0 trials
- Polycystic echinococcosis 0 trials
- Viral esophagitis 0 trials
- Viral gastritis 0 trials Sub-types →
-
Infectious disease with sepsis 383 trials · 475 incl. sub-types
1 sub-type
- Bacterial infectious disease with sepsis 78 trials · 113 incl. sub-types Sub-types →
-
Vector-borne disease 9 trials · 451 incl. sub-types
49 sub-types
- Malaria 135 trials · 170 incl. sub-types Sub-types →
- Dengue disease 75 trials Sub-types →
- Tick-borne infectious disease 9 trials · 42 incl. sub-types Sub-types →
- Chikungunya 31 trials
- Leishmaniasis 8 trials · 27 incl. sub-types Sub-types →
- Mycobacterium avium complex disease 22 trials
- Schistosomiasis 15 trials · 17 incl. sub-types Sub-types →
- Yellow fever 16 trials
- Zika virus infectious disease 15 trials
- Chagas disease 12 trials
- Filarial elephantiasis 9 trials
- Onchocerciasis 9 trials Sub-types →
- Arbovirus infection 8 trials
- Lassa fever 6 trials
- Crimean-Congo hemorrhagic fever 5 trials
- Mosquito-borne viral encephalitis 0 trials · 5 incl. sub-types Sub-types →
- Listeriosis 4 trials Sub-types →
- Plague 2 trials · 4 incl. sub-types Sub-types →
- Q fever 3 trials
- Rift valley fever 3 trials
- Human African trypanosomiasis 2 trials · 3 incl. sub-types Sub-types →
- Typhus 0 trials · 3 incl. sub-types Sub-types →
- Hantavirus hemorrhagic fever with renal syndrome, Puumala virus type 2 trials
- Hantavirus pulmonary syndrome 2 trials
- Relapsing fever 2 trials Sub-types →
- Oropouche fever 1 trial
- Venezuelan equine encephalitis 1 trial
- West Nile fever 1 trial Sub-types →
- Zika virus congenital syndrome 1 trial
- Lymphocytic choriomeningitis 1 trial
- Spotted fever 0 trials · 1 incl. sub-types Sub-types →
- Tungiasis 1 trial
- Alkhurma hemorrhagic fever 0 trials
- Argentine hemorrhagic fever 0 trials
- Bolivian hemorrhagic fever 0 trials
- Colorado tick fever 0 trials
- Hantavirus hemorrhagic fever with renal syndrome, Dobrava-Belgrade virus type 0 trials
- Hantavirus hemorrhagic fever with renal syndrome, Seoul virus type 0 trials
- Murray valley encephalitis 0 trials
- O'nyong'nyong fever 0 trials
- Ross river fever 0 trials
- Venezuelan hemorrhagic fever 0 trials
- Whitewater Arroyo hemorrhagic fever 0 trials
- Bacterial esophagitis 0 trials
- Fungal esophagitis 0 trials Sub-types →
- Phlebotomus fever 0 trials
- Rat-bite fever 0 trials Sub-types →
- Trench fever 0 trials
- Tularemia 0 trials Sub-types →
-
Skin disorder caused by infection 3 trials · 350 incl. sub-types
15 sub-types
- Skin infection 12 trials · 152 incl. sub-types Sub-types →
- Herpes zoster 73 trials Sub-types →
- Skin disease caused by bacterial infection 13 trials · 57 incl. sub-types Sub-types →
- Parasitic skin disorder 1 trial · 37 incl. sub-types Sub-types →
- Chickenpox 26 trials
- Common wart 26 trials
- Plantar wart 10 trials
- Virus-associated trichodysplasia spinulosa 10 trials
- Hand, foot and mouth disease 7 trials
- Viral exanthem 0 trials · 3 incl. sub-types Sub-types →
- Epstein-Barr virus hepatitis 0 trials
- Exanthema subitum 0 trials
- Herpetic whitlow 0 trials
- Infective dermatitis associated with HTLV-1 0 trials
- Variola major infectious disease 0 trials
-
Parasitic infectious disease 12 trials · 343 incl. sub-types
17 sub-types
- Protozoa infectious disease 3 trials · 242 incl. sub-types Sub-types →
- Helminthiasis 13 trials · 67 incl. sub-types Sub-types →
- Parasitic skin disorder 1 trial · 37 incl. sub-types Sub-types →
- Parasitic eye infection 0 trials · 16 incl. sub-types Sub-types →
- Parasitic intestinal disorder 0 trials · 16 incl. sub-types Sub-types →
- Cryptococcosis 5 trials · 10 incl. sub-types Sub-types →
- Demodicidosis 5 trials · 6 incl. sub-types Sub-types →
- Parasitemia 5 trials
- Coccidioidomycosis 4 trials
- Amoebiasis due to Entamoeba histolytica 1 trial
- Amoebiasis due to free-living amoebae 1 trial
- Strongylida infectious disease 0 trials
- Cutaneous larva migrans 0 trials Sub-types →
- Distomatosis 0 trials
- Microsporidiosis 0 trials Sub-types →
- Parasitic Ichthyosporea infectious disease 0 trials Sub-types →
- Parasitic myositis 0 trials Sub-types →
-
Fungal infectious disease 39 trials · 294 incl. sub-types
18 sub-types
- Opportunistic mycosis 0 trials · 148 incl. sub-types Sub-types →
- Cutaneous mycosis 1 trial · 118 incl. sub-types Sub-types →
- Fungal lung infectious disease 6 trials · 57 incl. sub-types Sub-types →
- Systemic mycosis 27 trials · 54 incl. sub-types Sub-types →
- Pneumocystis infectious disease 4 trials · 19 incl. sub-types Sub-types →
- Fungal meningitis 3 trials · 10 incl. sub-types Sub-types →
- Fungal infection of eye 0 trials · 7 incl. sub-types Sub-types →
- Scedosporiosis 2 trials
- Sporotrichosis 1 trial Sub-types →
- Alternariosis 0 trials Sub-types →
- Emergomycosis 0 trials
- Fungal discitis 0 trials
- Fungal esophagitis 0 trials Sub-types →
- Fungal gastritis 0 trials
- Fungal myositis 0 trials
- Invasive scopulariopsis infection 0 trials
- Mycotic endocarditis 0 trials
- Mycotoxicosis 0 trials Sub-types →
-
Urinary tract infection 156 trials · 250 incl. sub-types
5 sub-types
- Bacterial urinary tract infection 55 trials · 81 incl. sub-types Sub-types →
- Renal infectious disease 16 trials · 64 incl. sub-types Sub-types →
- Trichomonas vaginitis urogenital infection 7 trials Sub-types →
- Urinary schistosomiasis 3 trials
- Pyoureter 0 trials
-
Infectious disorder of the nervous system 4 trials · 232 incl. sub-types
10 sub-types
- Central nervous system infectious disorder 10 trials · 163 incl. sub-types Sub-types →
- Tetanus 44 trials Sub-types →
- Rabies 27 trials
- Tropical spastic paraparesis 3 trials
- Cytomegalovirus retinitis 2 trials
- Tabes dorsalis 2 trials
- Histoplasmosis retinitis 1 trial
- Ophthalmic herpes zoster 0 trials
- Postinfectious cerebellitis 0 trials
- Tick paralysis 0 trials
-
Nosocomial infection 115 trials · 116 incl. sub-types
3 sub-types
- Iatrogenic Kaposi's sarcoma 1 trial
- Iatrogenic Creutzfeldt-Jakob disease 0 trials
- Iatrogenic botulism 0 trials
-
Infective arthritis 25 trials · 100 incl. sub-types
2 sub-types
- Bacterial arthritis 24 trials · 94 incl. sub-types Sub-types →
- Infectious discitis 4 trials Sub-types →
-
Eye infectious disorder 4 trials · 61 incl. sub-types
10 sub-types
- Endophthalmitis 9 trials · 38 incl. sub-types Sub-types →
- Parasitic eye infection 0 trials · 16 incl. sub-types Sub-types →
- Viral eye infection 0 trials · 8 incl. sub-types Sub-types →
- Fungal infection of eye 0 trials · 7 incl. sub-types Sub-types →
- Hordeolum 1 trial · 7 incl. sub-types Sub-types →
- Bacterial conjunctivitis 3 trials Sub-types →
- Infectious panuveitis 1 trial
- Chronic canaliculitis 0 trials
- Infectious scleritis 0 trials
- Ocular tuberculosis 0 trials
-
Infective vaginitis 1 trial · 61 incl. sub-types
4 sub-types
- Bacterial vaginosis 44 trials
- Vulvovaginal candidiasis 25 trials
- Trichomonal vulvovaginitis 1 trial
- Herpetic vulvovaginitis 0 trials
-
Hemorrhagic fever 4 trials · 54 incl. sub-types
2 sub-types
- Viral hemorrhagic fever 10 trials · 51 incl. sub-types Sub-types →
- Bacterial hemorrhagic fever 0 trials · 3 incl. sub-types Sub-types →
-
Infective endocarditis 46 trials · 52 incl. sub-types
3 sub-types
- Bacterial endocarditis 15 trials
- Subacute bacterial endocarditis 4 trials
- Mycotic endocarditis 0 trials
-
Prosthesis-related infectious disease 49 trials
-
Ear infection 9 trials · 40 incl. sub-types
5 sub-types
- Infectious otitis media 24 trials
- Otitis externa 3 trials · 12 incl. sub-types Sub-types →
- Geniculate herpes zoster 0 trials
- Infectious otitis interna 0 trials
- Viral labyrinthitis 0 trials
-
Abscess 10 trials · 34 incl. sub-types
11 sub-types
- Breast abscess 5 trials
- Epidural abscess 5 trials
- Liver abscess (disease) 4 trials
- Peritonsillar abscess 4 trials
- Intracranial abscess 3 trials
- Lung abscess 3 trials
- Corneal abscess 1 trial
- Intersphincteric abscess 0 trials
- Pyoureter 0 trials
- Splenic abscess 0 trials
- Vitreous abscess 0 trials
-
Infectious embryofetopathy 2 trials · 25 incl. sub-types
10 sub-types
- Congenital herpes virus infection 0 trials · 15 incl. sub-types Sub-types →
- Congenital syphilis 7 trials Sub-types →
- Congenital toxoplasmosis 2 trials
- Congenital Epstein-Barr virus infection 0 trials
- Congenital enterovirus infection 0 trials
- Congenital rubella syndrome 0 trials
- Congenital varicella syndrome 0 trials
- Fetal enterovirus syndrome 0 trials
- Fetal parainfluenza virus type 3 syndrome 0 trials
- Fetal parvovirus syndrome 0 trials
-
Infectious peritonitis 22 trials · 23 incl. sub-types
3 sub-types
- Septic peritonitis 2 trials
- Diphtheritic peritonitis 0 trials
- Tuberculous peritonitis 0 trials
-
Nail infection 0 trials · 14 incl. sub-types
3 sub-types
- Tinea unguium 14 trials
- Fungal infection of the toenail 4 trials
- Herpetic whitlow 0 trials
-
Coinfection 12 trials
-
Hookworm infectious disease 10 trials
-
Puerperal infection 9 trials
-
Acanthamoeba infectious disease 0 trials · 5 incl. sub-types
2 sub-types
- Acanthamoeba keratitis 5 trials
- Granulomatous amebic encephalitis 0 trials
-
Epididymitis 2 trials
2 sub-types
- Epididymo-orchitis 0 trials Sub-types →
- Tuberculous epididymitis 0 trials
-
Mycetoma 1 trial
-
Ciliophora infectious disease 0 trials
1 sub-type
- Balantidiasis 0 trials
-
Hirudiniasis 0 trials
2 sub-types
- External hirudiniasis 0 trials
- Internal hirudiniasis 0 trials
-
Infectious myositis 0 trials
1 sub-type
- Parasitic myositis 0 trials Sub-types →
-
Protothecosis 0 trials
-
Pythiosis 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 3006 trials in this tab.
-
New antibiotic goes Head-to-Head with old guard in fight against tough skin infections
Cure CompletedResearchers are comparing ceftobiprole, an intravenous antibiotic, with a standard combination of vancomycin plus aztreonam for treating acute bacterial skin and skin structure infections in hospitalized adults. The trial enrolls adults with serious skin infections such as cellul…
Phase 3 • Sponsor: Basilea Pharmaceutica • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
On-the-Spot hep c care at methadone clinics boosts cure rates
Cure CompletedThis study tested whether offering hepatitis C (HCV) treatment right at methadone clinics helps more people get cured compared to sending them to outside specialists. Over 600 adults on opioid addiction therapy took part across 13 clinics in Ukraine. Some clinics provided simplif…
Sponsor: Ukrainian Institute on Public Health Policy • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a 4-Month drug cocktail cure TB as well as 6 months?
Cure CompletedResearchers in India are studying whether a 4-month daily regimen that includes moxifloxacin can cure newly diagnosed, microbiologically confirmed pulmonary tuberculosis as effectively as the standard 6-month treatment. The study enrolls 550 adults aged 18 to 65 who have not yet …
Sponsor: Tuberculosis Research Centre, India • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Two cheap creams go head to head against scabies mites
Cure CompletedScabies is a skin condition caused by mites that burrow into the skin and cause intense itching. This trial compares two creams used to treat it: sulfur 7% and permethrin 5%. Ninety adults with scabies were assigned to one cream or the other. Sulfur was applied each evening for t…
Phase 4 • Sponsor: Can Tho University of Medicine and Pharmacy • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Antibiotic showdown: can tigecycline match older drugs against tough skin infections?
Cure CompletedThis trial compares the antibiotic tigecycline with two older antibiotics, ampicillin-sulbactam and amoxicillin-clavulanate, in adults with complicated skin or skin structure infections that need intravenous treatment. About 550 participants receive one of the treatments for 4 to…
Phase 4 • Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
Two antibiotic cocktails face off to wipe out stomach bacteria
Cure CompletedResearchers compare two 14-day oral antibiotic regimens for eradicating Helicobacter pylori, the bacterium behind most stomach ulcers. One regimen combines bismuth, doxycycline, metronidazole, and esomeprazole; the other adds bismuth to clarithromycin, amoxicillin, and esomeprazo…
Phase 3 • Sponsor: Reham Abdelkader Elkhouly • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
Two-Drug malaria pill combo put to the test
Cure CompletedResearchers are testing two experimental oral antimalarial drugs, cipargamin and INE963, given alone or in combination, against standard malaria treatment. The trial enrolls people aged 12 and older who have uncomplicated falciparum malaria and weigh between 35 and 90 kilograms. …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
New oral drug candidate for two neglected parasitic diseases enters first human testing
Cure CompletedResearchers are running a first-in-human study of LXE408, an experimental oral tablet, to see how safe and well tolerated it is in healthy adults. About 88 healthy volunteers aged 18 to 65 will receive single or multiple ascending doses of LXE408 or a placebo. The study also meas…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
Can an 8-Week pill regimen cure hepatitis c?
Cure CompletedThis trial tests whether an 8-week course of the combination pill elbasvir/grazoprevir can cure chronic hepatitis C in people with genotype 1b who have not been treated before and have mild liver fibrosis. The main goal is to see if the virus stays undetectable 12 weeks after fin…
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Cure
Last updated Aug 26, 2026 00:00 UTC
-
New vaccine aims to protect african children from deadly salmonella
Vaccine CompletedThis study tests a new vaccine (iNTS-GMMA) designed to prevent severe Salmonella infections caused by two common strains. Researchers are giving the vaccine to healthy adults, children, and infants in Ghana to check if it is safe and triggers a strong immune response. The ultimat…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Sep 21, 2026 19:00 UTC
-
New infant vaccine targets 13 strains of pneumonia bacteria
Vaccine CompletedResearchers are testing whether a 13-valent pneumococcal conjugate vaccine is safe and prompts a strong immune response in healthy infants in India. The trial enrolls 708 infants who receive the vaccine or an older seven-strain version alongside their routine childhood shots. The…
Phase 3 • Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer • Aim: Vaccine
Last updated Sep 21, 2026 19:00 UTC
-
Can a tweaked bird flu shot build stronger immunity?
Vaccine CompletedResearchers are testing six different formulations of a cell culture-derived H2N3 influenza vaccine in about 600 healthy adults aged 18 and older. Participants receive two injections three weeks apart and are followed for about a year. The study measures antibody levels and check…
Phase 1 • Sponsor: Seqirus • Aim: Vaccine
Last updated Sep 21, 2026 19:00 UTC
-
Nasal spray vaccine aims to protect kids from two breathing viruses
Vaccine CompletedThis study tested two experimental nasal spray vaccines in 24 children aged 2 to 5 years. The vaccines target two viruses that can cause breathing problems: human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3). The main goal was to see if the vaccines are safe and …
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New mRNA flu shot shows promise in large trial for older adults
Vaccine CompletedThis large Phase 3 trial tested an experimental mRNA-based flu vaccine (mRNA-1010) against standard flu shots in over 40,000 adults aged 50 and older. The goal was to see if the new vaccine is safer and better at preventing flu-like illness caused by influenza A or B. Researchers…
Phase 3 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Sep 18, 2026 00:00 UTC
-
Promising lyme vaccine moves to next stage in human trials
Vaccine CompletedThis study tested a new vaccine called VLA15 to prevent Lyme disease, which is spread by tick bites. Researchers gave the vaccine or a placebo to 625 healthy people aged 5 to 65. The goal was to check safety and how well the vaccine triggers an immune response. Results showed the…
Phase 2 • Sponsor: Pfizer • Aim: Vaccine
Last updated Sep 17, 2026 00:00 UTC
-
New RNA mpox vaccine shows promise in early trial
Vaccine CompletedThis early-stage trial tested an RNA-based vaccine called BNT166a against mpox (monkeypox) in 96 healthy volunteers. The goal was to check safety and see if the vaccine triggers an immune response. Researchers looked for side effects like pain, fever, and fatigue, and monitored s…
Phase 1/2 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Sep 17, 2026 00:00 UTC
-
Does the EV71 vaccine last? new study checks kids years later
Vaccine CompletedThis study looks at whether an inactivated enterovirus 71 (EV71) vaccine still protects children two to two-and-a-half years after the last dose. It involves 126 healthy children from Vietnam who received the vaccine in an earlier phase 3 trial. Researchers will take a blood samp…
Sponsor: Enimmune Corporation • Aim: Vaccine
Last updated Sep 13, 2026 00:00 UTC
-
New mRNA vaccine targets brain infection in global trial
Vaccine CompletedThis study tests two new mRNA vaccines (GBP560) against Japanese encephalitis, a virus that can cause brain swelling. About 402 healthy adults will receive different doses of the vaccine or a comparison vaccine. Researchers will monitor safety and measure immune responses to find…
Phase 1/2 • Sponsor: SK Bioscience Co., Ltd. • Aim: Vaccine
Last updated Sep 13, 2026 00:00 UTC
-
Can a new shot stop a childhood virus that can attack the brain?
Vaccine CompletedResearchers are testing an inactivated enterovirus 71 (EV71) vaccine in healthy infants and children aged 2 months to 6 years. The trial aims to see if two shots of the vaccine can prevent hand, foot and mouth disease caused by EV71 and reduce severe complications like neurologic…
Phase 3 • Sponsor: Enimmune Corporation • Aim: Vaccine
Last updated Sep 13, 2026 00:00 UTC
-
Promising malaria vaccine trial launches for children in burkina faso
Vaccine CompletedThis study tests a new malaria vaccine called SUM-101 in 69 healthy children and infants aged 5 months to 5 years in Burkina Faso. The goal is to see if the vaccine is safe and triggers a strong immune response. Participants receive three doses, and some infants also receive a ra…
Phase 1 • Sponsor: European Vaccine Initiative • Aim: Vaccine
Last updated Sep 13, 2026 00:00 UTC
-
New sudan ebola vaccine shows promise in phase 2 trial
Vaccine CompletedThis study tested a new vaccine designed to protect against Sudan ebolavirus, a close relative of the Ebola virus. Researchers gave the vaccine or a placebo to 125 healthy adults to see if it is safe and triggers an immune response. The goal is to find a way to prevent this deadl…
Phase 2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: Vaccine
Last updated Sep 13, 2026 00:00 UTC
-
New coronavirus vaccine candidate enters first human tests
Vaccine CompletedResearchers are testing an experimental coronavirus vaccine called OVX033 in healthy adults aged 18 to 49 who have already received 2 to 4 doses of a licensed COVID-19 vaccine. The trial randomly assigns participants to receive one of three dose levels of OVX033 or a placebo, giv…
Phase 1 • Sponsor: Osivax • Aim: Vaccine
Last updated Sep 12, 2026 00:00 UTC
-
New mRNA flu vaccine shows promise in early human trial
Vaccine CompletedThis early-stage trial tested a new self-amplifying mRNA vaccine (ARCT-2304) designed to protect against pandemic influenza. 212 healthy adults aged 18-80 received either two doses of the experimental vaccine or one dose of a licensed flu vaccine plus placebo. Researchers monitor…
Phase 1/2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Vaccine
Last updated Sep 06, 2026 00:00 UTC
-
Can one shot replace six? a new vaccine aims to protect infants from six diseases at once
Vaccine CompletedResearchers are testing a new vaccine called LBVD that combines protection against diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib into a single injection. The study will enroll healthy infants aged 6 to 8 weeks, who will receive three doses at 6, 10, and 14 week…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Can a new vaccine bolster defenses against COVID-19?
Vaccine CompletedResearchers are testing an experimental vaccine called RBM-001 in healthy adults aged 18 to 55. The study aims to see if the vaccine is safe and triggers an immune response against COVID-19. Participants receive two doses, and researchers monitor for side effects and measure anti…
Phase 1 • Sponsor: Rock BioMedical, Inc. • Aim: Vaccine
Last updated Sep 04, 2026 00:00 UTC
-
Experimental herpes vaccine passes first safety check in small trial
Vaccine CompletedThis early-stage trial tested whether a new herpes vaccine called HSV529 is safe for people. Researchers gave the vaccine or a placebo to 69 healthy adults aged 18 to 40, some of whom had herpes and some who did not. Participants received three shots over six months and were moni…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 03, 2026 00:00 UTC
-
Can a second janssen shot cut severe COVID-19 in south africa?
Vaccine CompletedThis study tests whether a booster dose of the Janssen COVID-19 vaccine lowers the risk of severe COVID-19, hospitalizations, and deaths in adults who received a single Janssen shot at least six months earlier. Researchers will compare boosted participants with those who were not…
Phase 3 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Vaccine
Last updated Sep 03, 2026 00:00 UTC
-
Can new vaccines outsmart COVID-19 variants?
Vaccine CompletedThis trial tests two experimental COVID-19 vaccines, AZD9838 and AZD6563, in adults to see if they are safe and trigger a strong immune response. Participants receive a single injection of one of the vaccines or a licensed mRNA vaccine for comparison. The study measures side effe…
Phase 1 • Sponsor: AstraZeneca • Aim: Vaccine
Last updated Sep 02, 2026 00:00 UTC
-
Could a nasal spray stop the next flu pandemic?
Vaccine CompletedThis early-stage trial tests an experimental nasal spray vaccine called BW-1014, designed to protect against pandemic flu. Healthy adults aged 18 to 45 receive two doses of the spray, with or without a nanoemulsion adjuvant, followed by a standard flu shot six months later. Resea…
Phase 1 • Sponsor: BlueWillow Biologics • Aim: Vaccine
Last updated Aug 01, 2026 00:00 UTC
-
Ebola vaccine trial aims to shield frontline workers in congo
Vaccine CompletedThis study tests a two-dose Ebola vaccine regimen in healthcare workers in the Democratic Republic of the Congo, who are at high risk during outbreaks. Participants receive an initial shot of Ad26.ZEBOV followed by a booster of MVA-BN-Filo 56 days later. Some will also get an add…
Phase 2 • Sponsor: Universiteit Antwerpen • Aim: Vaccine
Last updated Jul 16, 2026 00:00 UTC
-
Could a vaccine given during pregnancy shield infants from a deadly virus?
Vaccine CompletedThis study tests an RSV vaccine in pregnant women living with HIV. The goal is to see if the vaccine is safe and helps mothers pass protective antibodies to their babies, potentially preventing severe RSV lung infections in infants. The trial involves about 681 pregnant participa…
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jul 04, 2026 00:00 UTC
-
Meningitis b vaccine shows promise in children
Vaccine CompletedThis study looked at how well the MenBVac vaccine protects children against a specific type of meningitis B bacteria. Researchers measured the immune response in 218 children who had already received five doses of the vaccine. The goal was to see if the children had enough antibo…
Phase 4 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:08 UTC
-
Does the meningitis b vaccine last? study tests kids 4 years later
Vaccine CompletedThis study looked at 117 children aged 4-8 who had received four doses of the MenBVac vaccine against meningitis B. Researchers measured how many still had protective antibodies four years after the last dose. The goal was to see if the vaccine's immunity lasts over time.
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
Which sedation approach helps pneumonia patients breathe on their own sooner?
Disease control CompletedResearchers at Xiangya Hospital of Central South University are comparing different sedation regimens used for patients with severe pneumonia in the intensive care unit. The study looks at 260 patients and measures how long they need mechanical ventilation, how well sedation targ…
Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
New COVID pill shows promise in early trial
Disease control CompletedThis completed Phase 2 study tested an oral antiviral drug called S-892216 in 282 adults with mild-to-moderate COVID-19. Participants took either the drug or a placebo tablet for a short time. The main goal was to see if the drug could lower the amount of virus in the nose and th…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
New study tests better ways to link former inmates to HIV and addiction treatment
Disease control CompletedThis study tested two different approaches to help people recently released from jail or prison get connected to care for HIV, hepatitis C, STIs, and opioid use disorder. Over 600 adults took part. The goal was to see which method worked better for starting and staying on treatme…
Sponsor: Yale University • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Can fewer HIV drugs keep the virus just as suppressed?
Disease control CompletedResearchers are testing whether switching from a standard three-drug HIV regimen to a two-drug regimen keeps the virus under control just as well. The trial enrolls 134 adults whose HIV is already suppressed on a three-drug regimen and randomly assigns them to continue that regim…
Phase 4 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Can remote counseling help people with HIV cut back on alcohol?
Disease control CompletedResearchers are testing whether a telehealth counseling program can reduce heavy drinking and improve HIV viral control in people with HIV. Participants receive either a single brief alcohol counseling session or that session plus a referral to a program with multiple video couns…
Sponsor: Brown University • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Could a stem cell drug tame rare immune disease?
Disease control CompletedThis early-phase study tests whether Mozobil, a drug already used to boost stem cells for transplants, can safely raise white blood cell counts in people with WHIMS. WHIMS is a rare genetic condition that traps infection-fighting cells in the bone marrow, leading to frequent infe…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 21, 2026 19:00 UTC
-
Wellness and peer support may boost HIV care for India's sexual minorities
Disease control CompletedThis study adapts a wellness program called Chetana to help men who have sex with men (MSM) and transgender women (TGW) in India who are living with HIV stay engaged in care. The program includes yoga, nutrition, legal advice, mental health support, and peer navigators who provid…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
HIV shot could replace daily pills for those who skip doses
Disease control CompletedThis study tested whether monthly injections of two HIV drugs (cabotegravir and rilpivirine) work better than daily oral pills for people with HIV who have a history of missing doses. Over 450 participants were enrolled. The goal was to see if the long-acting shots reduce the cha…
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Simple breathing moves may help young children fight pneumonia
Disease control CompletedThis study tests whether special breathing techniques called neurophysiological facilitation of respiration can improve oxygen levels and shorten hospital stays in children aged 6 months to 2 years with pneumonia. The techniques involve gentle stretches and co-contraction of the …
Sponsor: Asmaa Ahmed Abd El-samad • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
Disease control CompletedResearchers are testing two ways to give the HIV drug dolutegravir to people who also have tuberculosis and are taking rifampin-based TB therapy. Rifampin can lower dolutegravir levels in the body, so the trial compares taking 50 mg once daily with food against taking 50 mg twice…
Phase 2 • Sponsor: The HIV Netherlands Australia Thailand Research Collaboration • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug TdCyd aims to reactivate Tumor-Fighting genes in advanced cancer
Disease control CompletedThis early-phase trial tested a new drug called TdCyd in 27 adults with advanced solid tumors that had stopped responding to standard treatments. The drug is designed to turn back on genes that may slow tumor growth. The main goal was to find a safe dose and check for side effect…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Poop pills could stop recurrent UTIs without antibiotics
Disease control CompletedThis completed Phase 2 trial tested fecal microbiota transfer (FMT) – a freeze-dried product made from healthy donor stool – in 40 women with recurrent urinary tract infections (UTIs). The goal was to see if FMT could prevent future UTIs by restoring healthy gut bacteria. Researc…
Phase 2 • Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can nurse counseling and daily texts keep HIV prevention pills on track?
Disease control CompletedResearchers at the University of Miami are testing two ways to help men who have sex with men take their HIV prevention medication, known as PrEP, more consistently. One group receives four weekly counseling sessions with a nurse, using techniques from cognitive behavioral therap…
Sponsor: University of Miami • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can neighbors deliver HIV care? cambodia trial puts community model to the test
Disease control CompletedResearchers are studying whether trained community workers can safely deliver HIV treatment outside clinics in Cambodia. The trial enrolls about 4,000 people living with HIV who have stable treatment and no complications. Community action workers receive training to dispense drug…
Sponsor: National University of Singapore • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Chemotherapy plus immunotherapy tested against rare EBV-Driven immune storm
Disease control CompletedResearchers are testing a combination of L-DEP chemotherapy (aspargase, liposomal doxorubicin, etoposide, and methylprednisolone) and a PD-1 antibody as initial treatment for people with Epstein-Barr virus-positive lymphoma-associated hemophagocytic lymphohistiocytosis, a rare an…
Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Experimental drug shows promise for rare immune disorders
Disease control CompletedThis early-phase study tested the safety of rituximab, a drug that targets faulty white blood cells, in 7 adults with rare immune diseases like pulmonary alveolar proteinosis and severe candidiasis. Participants received several doses over 6 months and were monitored for 18 month…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to help HIV patients manage substance use and stay on track with meds
Disease control CompletedThis study tests a new program to help people with HIV who also use substances stick to their HIV medications and stay in care. The program teaches coping skills and ways to manage substance use. Researchers want to see if the program is practical and acceptable to participants. …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a phone app keep young people with HIV engaged in care?
Disease control CompletedResearchers at UT Health San Antonio are testing a mobile app called PL4Y to see if it helps young people recently diagnosed with HIV stay connected to medical care. The pilot study enrolls 29 participants who either have a recent diagnosis, a high viral load, or have missed HIV …
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a cancer drug combo fight frailty in HIV?
Disease control CompletedThis Phase 2 trial tests whether a combination of dasatinib and quercetin (D+Q) can safely improve physical function in 82 older adults with HIV who are frail or prefrail. Participants take D+Q or a placebo in six 2-day cycles over 12 weeks, then are monitored for another 12 week…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New shot aims to cure chronic hepatitis b – early trial underway
Disease control CompletedThis study tests a new drug called AHB-137 in 86 adults with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if AHB-137 can clear the hepatitis B surface antigen from the blood, which would mean the virus is under control and patients might be …
Phase 2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Laser vs. electric scalpel: which removes genital warts better?
Disease control CompletedThis trial compares two surgical methods—carbon dioxide laser ablation and electrocoagulation—for removing genital warts in women. The main goal is to see which technique gives a better cosmetic result six weeks after treatment. Researchers also track operation time, complication…
Sponsor: Ruhr University of Bochum • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a five-day pill course cut COVID-19 deaths? czech nationwide data puts molnupiravir to the test.
Disease control CompletedThis study uses health records from over 1.8 million adults in the Czech Republic to see if the antiviral drug molnupiravir lowers the risk of dying from COVID-19 during the Omicron wave. Researchers compare people who received molnupiravir plus standard care with similar patient…
Sponsor: Charles University, Czech Republic • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could less food help critically ill patients recover faster?
Disease control CompletedNUTRIREA-3 compares two feeding strategies for adults on ventilators with shock. One group receives low-calorie low-protein feeding for the first week, while the other receives standard-calorie standard-protein feeding. Researchers track survival and time to leave the ICU to see …
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Blood test vs. clinical check: which safely cuts antibiotic use in pneumonia?
Disease control CompletedResearchers compare two approaches to managing antibiotics in adults hospitalized with community-acquired pneumonia. One approach uses doctors' clinical reassessment to decide whether to continue, stop, or change antibiotics. The other uses blood levels of a marker called procalc…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Gut bacteria transplant tested against Antibiotic-Resistant urinary infections
Disease control CompletedResearchers are testing whether transplanting a purified mix of gut bacteria from healthy donors can clear urinary tract infections caused by multidrug-resistant organisms. About 10 adults with recurrent resistant UTIs will receive the transplant three times through a tube placed…
Phase 1/2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can one daily dose of raltegravir keep HIV in check?
Disease control CompletedResearchers are testing whether a once-daily form of raltegravir can keep HIV suppressed in adults who already have the virus under control with standard antiretroviral therapy. The trial enrolls about 100 adults with HIV-1 who have been on stable treatment for at least six month…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can common kidney drugs weaken the smallpox antiviral TPOXX?
Disease control CompletedResearchers are testing whether four common phosphate binders change how the body processes the smallpox antiviral TPOXX. The study enrolls 44 healthy adults aged 18 to 50 with normal phosphorus levels. Each participant receives TPOXX alone and with each binder in a five-period c…
Phase 4 • Sponsor: SIGA Technologies • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Smallpox drug put to the test in heavier adults
Disease control CompletedResearchers are studying the smallpox antiviral TPOXX in adults who weigh more than 120 kg. The trial measures how the drug moves through the body and checks for side effects over a week of dosing. The goal is to see whether this group processes the drug differently, which could …
Phase 4 • Sponsor: SIGA Technologies • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a probiotic shield kids from antibiotic side effects?
Disease control CompletedThis study tests whether giving a probiotic (Saccharomyces boulardii) along with a common antibiotic can protect the gut bacteria of children aged 4 to 12 being treated for ear or sinus infections. The goal is to see if it reduces antibiotic-associated diarrhea and limits the spr…
Phase 4 • Sponsor: Eskisehir Osmangazi University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Three-Drug antifungal cocktails put to the test against stubborn skin fungus
Disease control CompletedDermatophytosis, a common fungal skin infection, often becomes chronic and resists standard treatment. Researchers are comparing three oral antifungal combinations: terbinafine plus fluconazole, terbinafine plus itraconazole, and terbinafine plus voriconazole. The trial enrolls 1…
Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can better testing and TB prevention keep advanced HIV patients alive?
Disease control CompletedResearchers are studying whether an enhanced package of care helps people with advanced HIV in Malawi stay in treatment and keep the virus suppressed. The package adds CD4 and TB-LAM tests and starts patients on TB preventive therapy, delivered through a hub-and-spoke system of c…
Sponsor: Elizabeth Glaser Pediatric AIDS Foundation • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Once-a-Week IV antifungal tested against daily standard for dangerous candida infections
Disease control CompletedResearchers are testing an experimental intravenous antifungal called HRS9432 in adults with candidemia or invasive candidiasis, serious infections caused by Candida yeast. The trial compares HRS9432 given once a week with caspofungin, a standard antifungal given daily. The main …
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can an oral drug stop COVID-19 from turning deadly?
Disease control CompletedResearchers are testing an experimental oral drug called sabizabulin (VERU-111) in hospitalized adults with confirmed SARS-CoV-2 infection who are at high risk for acute respiratory distress syndrome (ARDS). Participants receive either sabizabulin plus standard care or a placebo …
Phase 3 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Which IV fluid works best for sepsis after surgery? new study aims to find out
Disease control CompletedThis study compares two common IV fluids—Ringer's Lactate and Sterofundin/Plasmalyte—in adults with sepsis after abdominal surgery. Researchers will measure how well each fluid helps clear lactate from the blood and supports kidney function. The goal is to find which fluid leads …
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Antifungal isavuconazole under study for rare brain infection
Disease control CompletedCerebral aspergillosis is a rare and serious brain infection caused by a mold. Doctors often use voriconazole as the first treatment, but a newer drug called isavuconazole may work as well with fewer side effects. This study looks back at the medical records of 41 children and ad…
Sponsor: Imagine Institute • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Boric acid inserts aim to cure yeast infections in new trial
Disease control CompletedThis study tests whether boric acid vaginal inserts (600 mg) taken for 7 or 14 days can safely and effectively treat yeast infections. About 400 women aged 12 and older with active symptoms will participate. The goal is to see if all signs and symptoms disappear without needing m…
Phase 3 • Sponsor: pH-D Feminine Health LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Nanochitosan paste takes on denture fungal infections
Disease control CompletedResearchers are testing whether a 5% nanochitosan paste can treat oral candidosis, a fungal infection common under dentures. The trial compares this experimental paste with a standard nystatin ointment in 30 adults who wear full dentures and have type 2 denture stomatitis. Partic…
Phase 2 • Sponsor: Kerman University of Medical Sciences • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New booster vaccine trial aims to shield japanese teens from three serious diseases
Disease control CompletedThis study tests a single booster dose of a combined vaccine against diphtheria, tetanus, and whooping cough (dTpa) in 85 healthy Japanese adolescents aged 11 to 13. Researchers will check if the shot triggers a strong immune response and monitor for side effects one month after …
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can starting TB treatment immediately save lives in HIV sepsis?
Disease control CompletedIn sub-Saharan Africa, tuberculosis often causes sepsis in people living with HIV, and many die within days. This phase 3 trial tests two changes to standard care: starting anti-TB therapy right away instead of waiting for test results, and using a higher, sepsis-specific dose in…
Phase 3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Nanobody drug tested against painful skin condition
Disease control CompletedResearchers are testing a drug called sonelokimab in adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and abscesses. The trial compares sonelokimab, given by injection, with a placebo and with adalimumab, an existing trea…
Phase 2 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a Two-Drug HIV pill hold the line when resistance lurks?
Disease control CompletedResearchers are testing whether a daily pill combining dolutegravir and lamivudine keeps HIV suppressed in adults whose virus is already under control but who have a history of resistance to lamivudine. The study enrolls 167 participants who switch from their current HIV treatmen…
Phase 2 • Sponsor: Fundacion SEIMC-GESIDA • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Telehealth program aims to get HIV treatment to people who inject drugs faster
Disease control CompletedThis study tested two ways to offer HIV treatment, hepatitis C treatment, and substance use disorder medications to people who inject drugs. One group received a telehealth-enhanced program with on-demand services like mobile blood draws and counseling, while the other group got …
Sponsor: University of Miami • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New vaccine aims to shield leukemia patients from COVID-19
Disease control CompletedThis phase 2 trial tests a new COVID-19 booster vaccine (GEO-CM04S1) in 80 people with chronic lymphocytic leukemia (CLL). The goal is to see if this vaccine triggers a stronger immune response than standard mRNA boosters. Participants will receive either the new vaccine or a sta…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a common arthritis drug tame the painful Flare-Ups of leprosy?
Disease control CompletedThis trial tests whether adding methotrexate to the standard steroid prednisolone better controls erythema nodosum leprosum (ENL), a painful and often recurring complication of leprosy. Adults aged 18 to 65 with active ENL will receive either prednisolone alone or prednisolone pl…
Phase 1 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new interferon tame hepatitis d?
Disease control CompletedThis phase 2 trial tests whether peginterferon lambda, an experimental interferon drug, can safely reduce hepatitis D virus levels in people with chronic infection. Participants receive one of two doses of the drug for 48 weeks, and researchers measure changes in viral load and l…
Phase 2 • Sponsor: EIT Pharma, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can mentorship and skills training boost resilience in HIV-Positive teen moms?
Disease control CompletedThis study evaluates a program for HIV-positive adolescent girls and young women who are pregnant or parenting. The program offers education on sexual health, support groups, skills development, mentorship, and involvement of young fathers. Researchers will measure resilience and…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New dental cements could save painful teeth from root canals
Disease control CompletedThis study tests two calcium silicate-based dental cements, Biodentine and NeoPutty, for treating irreversible pulpitis (severe tooth nerve inflammation) in adults. Sixty participants with deep cavities and spontaneous pain will receive a single-session pulpotomy, where the infla…
Phase 4 • Sponsor: Firat University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Green light and pink dye take on tough eye infections
Disease control CompletedThis study tested whether adding a light-activated dye (rose bengal) to standard antibiotic or antifungal eye drops could improve vision in people with severe corneal infections. About 330 adults in India and Brazil with fungal or amoeba infections received either standard drops …
Phase 3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can kidneys from HIV-Positive donors save more lives?
Disease control CompletedThis trial tests whether kidneys from deceased HIV-positive donors can be safely transplanted into people living with HIV. Researchers track major complications like graft failure, serious side effects, and HIV progression. The goal is to see if using these organs is a safe way t…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New bacteria slurry takes on poop transplants for stubborn gut infection
Disease control CompletedThis study tests two treatments for people with repeat C. diff infections: a lab-made bacteria mix called MTC01 and a fecal transplant (FMT) from a healthy donor. Both are given during a colonoscopy. The goal is to see which is safer and better at stopping the infection from comi…
Phase 1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Poop pills could protect gut after colon surgery – early trial begins
Disease control CompletedThis early-stage trial is testing whether a pill made from freeze-dried healthy donor stool (MTP-101P) is safe and can restore good bacteria in people having part of their colon removed. Forty adults aged 18-75 with colon polyps, early-stage cancer, or diverticulitis will take th…
Phase 1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a heart drug save lives in septic shock? new trial aims to find out.
Disease control CompletedThis study tests a drug called ivabradine in 429 adults with septic shock, a life-threatening condition where infection causes dangerously low blood pressure. Many patients develop a fast heart rate, which can worsen outcomes. Ivabradine slows the heart without weakening its pump…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Zinc gel may outsmart recurring yeast infections
Disease control CompletedThis trial tests whether adding a zinc-containing vaginal gel to the standard yeast infection pill can lower the chance of the infection returning. About 64 women with a current yeast infection will receive either the standard single dose of fluconazole alone or fluconazole follo…
Sponsor: FEMPHARMA Kft. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
A gel that may help the cervix heal from HPV lesions faces a test
Disease control CompletedThis trial tests whether a vaginal gel called Papilocare can repair cervical lesions caused by high-risk human papillomavirus (HPV). Researchers plan to include 164 women aged 30 to 65 who have abnormal cervical cell results and test positive for high-risk HPV. Participants will …
Sponsor: Procare Health Iberia S.L. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New Short-Course malaria treatment could prevent relapses
Disease control CompletedThis study tested a new approach to treat vivax malaria, a type that can hide in the liver and come back. Researchers used a quick test to check for a genetic condition (G6PD deficiency) that can cause dangerous side effects with the standard drug primaquine. Then, they gave a hi…
Sponsor: Macfarlane Burnet Institute for Medical Research and Public Health Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a pill replace an IV for Drug-Resistant shigella in children?
Disease control CompletedThis trial tests whether an oral antibiotic called tebipenem-pivoxil works as well as the standard IV antibiotic ceftriaxone for children with shigellosis, a severe diarrheal disease, when first-line treatment fails. The study enrolls children aged 24 to 59 months who have not im…
Phase 2 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a higher dose of rifampicin clear TB around the heart faster?
Disease control CompletedThis trial tests whether giving a higher dose of the antibiotic rifampicin (35 mg/kg) can increase drug levels in the fluid around the heart and clear tuberculosis bacteria faster than the standard dose (10 mg/kg). The study enrolls adults with suspected tuberculous pericarditis,…
Phase 2 • Sponsor: University of Cape Town • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Old HIV drugs get a second look in Long-Term study
Disease control CompletedThis study compares three treatments for early HIV infection: zidovudine (AZT) alone, alpha-interferon alone, or both together. It aims to see which best lowers viral load, protects the immune system, and delays the first serious infection. About 180 adults with early HIV and hea…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
A game may help teens with HIV stick to treatment
Disease control CompletedResearchers are testing a smartphone game called MyGoals to see if it can help adolescents living with HIV in Kenya stay engaged in their care. The game includes role-playing, mini-games, and personal goal-setting to boost knowledge, attitudes, and confidence around treatment and…
Sponsor: Emory University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New mobile program aims to help HIV-Positive veterans kick the habit
Disease control CompletedThis study tested a mobile phone-based wellness program (WISH) to help veterans with HIV quit smoking. 234 participants were split into two groups: one received the WISH program, the other got standard care (quitline and text support). The goal was to see if the wellness program …
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can an arthritis drug speed COVID-19 recovery? new trial tests abatacept
Disease control CompletedThis study tested whether the immune-modulating drug abatacept, given early to hospitalized COVID-19 patients on low-flow oxygen, helps them recover faster compared to a placebo. A total of 285 adults participated. The goal was to see if adding abatacept to standard care improves…
Phase 4 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a new pill shorten tuberculosis treatment?
Disease control CompletedThis trial tests an experimental antibiotic called BTZ-043 in adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. Participants take the drug by mouth once daily for 14 days, and researchers compare it to a standard combination treatment. The main goal is to check …
Phase 1/2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can smartphone coaching help young zambians with HIV stay healthy?
Disease control CompletedThis study is testing two mobile health tools—a computer-delivered program and motivational text messages—to help young adults (ages 18-24) in Zambia better manage their HIV and cut down on alcohol use. The goal is to see if these tools are easy to use and acceptable to participa…
Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can Trauma-Focused coping skills boost HIV suppression in women?
Disease control CompletedThis trial tests a counseling program called ImpACT+ for women in South Africa who have HIV and a history of sexual trauma. The program combines HIV treatment adherence support with coping skills to address traumatic stress. Researchers will compare viral suppression rates and ca…
Sponsor: Columbia University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could moving HIV care out of hospitals boost satisfaction and cut carbon?
Disease control CompletedThis pilot study tests whether people with HIV who receive routine care at a community center, instead of a hospital, feel more satisfied with their care. Researchers will compare satisfaction between two groups: one getting care at the community facility and one continuing usual…
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a 3-Day drug beat the standard for amoeba diarrhea in kids?
Disease control CompletedThis trial tests two medicines, nitazoxanide and metronidazole, to see which works better for diarrhea caused by Entamoeba histolytica in children. About 90 children aged 2 to 15 with confirmed amoeba infection will be randomly assigned to one of the two drugs. Nitazoxanide is gi…
Phase 2 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a simple Follow-Up program keep HIV patients healthier after leaving the hospital?
Disease control CompletedThis study tests whether a structured transition-of-care program can improve support for adults in Malawi who are hospitalized with both HIV and a chronic condition like high blood pressure. The program includes discharge planning, nurse home visits within a week, and community f…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Texting away UTIs: could a phone platform cut unnecessary antibiotics?
Disease control CompletedThis trial tests whether an EHR-integrated texting platform, called Urotrust, can help women with recurrent urinary tract infections (UTIs) manage their condition better than usual care. The platform provides symptom triage, clinical guidance, and prevention education via text me…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a 5-Day pill tame RSV in the most vulnerable?
Disease control CompletedThis trial tests an experimental antiviral pill, EDP-938, in adults with a confirmed RSV infection who are at high risk for complications—such as those over 65 or with asthma, COPD, or heart failure. Participants take the drug or a placebo once daily for five days. The goal is to…
Phase 2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New antibiotic vabomere tested in kids for first time
Disease control CompletedThis study is testing a single dose of the antibiotic Vabomere in 39 children from birth to under 18 years old who have serious bacterial infections. The goal is to find the right dose and check how safe and tolerable the drug is. All children are hospitalized and receiving other…
Phase 1 • Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Cash for care: a simple incentive to keep HIV patients on track
Disease control CompletedThis trial tests whether offering small cash payments to people living with HIV, when they attend counseling sessions and clinic visits, can help them stay engaged in care and achieve viral suppression. Participants are adults identified as high risk for dropping out of care at t…
Sponsor: University of California, Berkeley • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Iron pills may give female footballers a performance edge
Disease control CompletedThis pilot study looks at whether a daily low-dose iron supplement (27 mg for three months) can improve iron status, gut health, and endurance in young female elite football players. Researchers will track diet, blood markers like hemoglobin and ferritin, gut leakage indicators, …
Sponsor: Norwegian University of Life Sciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Bringing HIV care to the community: a new test in zambia
Disease control CompletedThis study in Zambia is testing whether community-based and streamlined models of antiretroviral therapy (ART) care can help people living with HIV stay in treatment. It involves about 3,100 HIV-positive adolescents and adults who are not acutely ill. Participants may receive car…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a smart oxygen device shorten hospital stays for pneumonia?
Disease control CompletedThis trial tests whether an automated oxygen delivery system, called FreeO2, can help patients with pneumonia recover faster and leave the hospital sooner. The device automatically adjusts oxygen flow based on continuous monitoring of blood oxygen levels, aiming to keep patients …
Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a new IV antiviral tame two stubborn viruses?
Disease control CompletedThis trial is testing an experimental drug called brincidofovir, given intravenously, in people aged 2 months and older who have an adenovirus or cytomegalovirus infection. The study aims to see how safe and tolerable different doses are, and whether the drug can reduce the amoun…
Phase 2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can At-Home malaria pills work as well as supervised care?
Disease control CompletedThis trial compares two ways of taking the standard malaria treatment for Plasmodium vivax: one group receives chloroquine and primaquine under direct medical supervision, while the other takes the same medication at home with phone check-ins. The goal is to see if unsupervised t…
Sponsor: Jimma University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
A pharmacist's touch: could structured medication reviews boost HIV treatment success?
Disease control CompletedThis trial tests whether a structured, pharmacist-led medication management program can help HIV patients at high risk of drug-related problems take their medications more consistently. Participants are randomly assigned to usual care, a basic program, or an enhanced program with…
Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Peer support may curb HIV stigma and stress in vietnamese gay men
Disease control CompletedThis trial tests a community-based program called VINA STEAM, designed to help gay and bisexual men in Ho Chi Minh City cope with stress and HIV-related stigma. Participants join small peer-led groups to build skills that may reduce minority stress and stigma. The study measures …
Sponsor: Florida State University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a shorter TB regimen transform child care?
Disease control CompletedThis study looks at how a shorter tuberculosis (TB) treatment regimen works for children and adolescents with non-severe TB in Zambia. It involves children, caregivers, health workers, and policymakers to understand how well the regimen is accepted, followed, and feasible in real…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a simple wipe slash hospital infections?
Disease control CompletedThis study tests whether using pre-moistened wipes without water for perineal hygiene is more effective than traditional soap and water in reducing skin microbes in totally dependent hospital patients. About 468 adults in medical or geriatric wards will be randomly assigned to on…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a new HIV drug combo better protect pregnant women and their babies?
Disease control CompletedThis phase 3 trial asks whether a dolutegravir-based HIV regimen works as well as or better than an efavirenz-based regimen in pregnant women living with HIV-1. The study compares how well each treatment suppresses the virus at delivery and checks safety for both mothers and thei…
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can umbilical cord stem cells ease a scarring lung disease?
Disease control CompletedThis early-stage trial is testing an experimental stem cell therapy called VUM02 in people with idiopathic pulmonary fibrosis (IPF), a condition that causes progressive lung scarring and breathing difficulty. The study aims to see if the treatment is safe and tolerable, and wheth…
Phase 1 • Sponsor: Wuhan Optics Valley Vcanbiopharma Co., Ltd. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Herbal granules may knock out cold symptoms in three days — a rigorous trial puts them to the test
Disease control CompletedThis phase 3 trial tests whether Jinhua Qinggan Granules, a traditional Chinese herbal medicine, can eliminate symptoms of acute upper respiratory infections (like fever, sore throat, and congestion) within three days. About 273 adults with early-stage cold or flu will receive ei…
Phase 3 • Sponsor: University of Karachi • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Triple threat: could three malaria drugs together beat resistance?
Disease control CompletedThis trial tests whether giving children with uncomplicated malaria a triple combination of artemisinin-based drugs works better than the standard two-drug treatment. The goal is to see if using three drugs together can delay the malaria parasite from becoming resistant. Children…
Phase 2/3 • Sponsor: Muhimbili University of Health and Allied Sciences • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A new drug combo may shield kidney transplant patients from a common viral threat
Disease control CompletedThis trial compares two immunosuppressive regimens in CMV-positive kidney transplant recipients. One group receives everolimus with a reduced dose of cyclosporine A, while the other gets standard mycophenolic acid with full-dose cyclosporine. The goal is to see whether the everol…
Phase 4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a new shot help control hepatitis d in people with hepatitis b?
Disease control CompletedThis phase 2 trial is testing whether adding an experimental drug called JNJ-73763989 to standard oral antivirals can better suppress hepatitis D virus in people who are also infected with hepatitis B. About 52 adults with stable chronic co-infection will receive either the combi…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could giving TB pills on day one save more lives?
Disease control CompletedThis study tested a new strategy: giving TB prevention medicine at the same time as TB testing to people with HIV starting or restarting antiretroviral therapy. The goal was to see if this approach gets more people on TB prevention quickly without missing active TB cases. The tri…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Pharmacy-Based hepatitis c testing could cure more people on opioid therapy
Disease control CompletedThis study tests whether offering hepatitis C testing right in community pharmacies—using a simple finger-prick device—helps more people on opioid therapy get diagnosed and cured compared to the usual approach of referring them to a clinic. Participants are adults on stable metha…
Sponsor: University of Dundee • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Virtual worlds could help men with HIV fight heart disease
Disease control CompletedThis study tests whether a virtual environment (VE) can help minority men who have sex with men and are living with HIV adopt healthier behaviors to prevent cardiovascular disease. Participants use a computer-based virtual world to access educational quests and other features. Th…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a common antibiotic beat yaws? new trial puts linezolid to the test
Disease control CompletedThis phase 3 trial investigates whether the antibiotic linezolid can cure yaws, a bacterial skin infection that causes ulcers, as effectively as the standard treatment azithromycin. The study involves 384 children aged 5 to 18 with confirmed yaws. Participants receive either line…
Phase 3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Long-acting HIV shot studied in patients with severe kidney problems
Disease control CompletedThis study looks at whether CABENUVA, a long-acting injectable HIV medication, is safe and effective for people with HIV who also have severe kidney impairment, including those on dialysis. Participants receive the drug as monthly or every-2-month injections. The goal is to see h…
Phase 3 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Hospital care model aims to treat opioid addiction and serious infections together
Disease control CompletedThis study tests a care model where hospitalized adults with opioid use disorder and a serious infection receive long-acting injectable buprenorphine from their infectious disease doctors, alongside infection treatment. The goal is to keep patients on effective medication for opi…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Engineered virus takes on liver cancer when standard treatment fails
Disease control CompletedThis trial investigates whether JX-594 (Pexa-Vec), a virus modified to attack cancer cells and boost the immune system, combined with best supportive care, can help people with advanced liver cancer live longer. The study enrolls adults whose liver cancer has progressed or who co…
Phase 2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New decolonization method could lower infection risk in spine surgery
Disease control CompletedThis pilot study compares a new decolonization regimen using polyhexanide (nasal gel and body foam) to the standard mupirocin and chlorhexidine treatment for reducing Staphylococcus aureus bacteria before elective spine surgery. The trial includes 24 adults who carry Staph bacter…
Phase 4 • Sponsor: Swiss Paraplegic Research, Nottwil • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a single antibiotic dose before hip replacement be just as effective as multiple doses?
Disease control CompletedThis trial investigates whether a single dose of antibiotics before hip replacement surgery prevents joint infections as effectively as multiple doses. The study involves about 20,000 adults with osteoarthritis undergoing hip replacement at hospitals across Denmark. Researchers w…
Sponsor: Soren Overgaard • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could assigning one main nurse to each patient cut hospital infections and falls?
Disease control CompletedThis study tests a care model where each hospital patient is assigned one main nurse who plans and oversees all their care. Researchers want to see if this reduces infections, falls, and pressure injuries, and improves patient and nurse satisfaction. The study involves over 1,700…
Sponsor: Università degli Studi del Piemonte Orientale Amedeo Avogadro • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a lower dose of an old antibiotic tame Drug-Resistant TB?
Disease control CompletedThis study tests whether a low daily dose of the antibiotic linezolid, added to a personalized combination of other drugs, is safe and tolerable for people with multidrug-resistant tuberculosis (MDR-TB). Participants take either linezolid or a placebo for 16 weeks, alongside thei…
Phase 1/2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a short video and counseling session reduce HIV stigma in pregnancy care?
Disease control CompletedThis study tests a program called Maisha (Swahili for 'life') that aims to reduce HIV stigma among pregnant women and their male partners entering antenatal care in Tanzania. The program includes a video and counseling session before HIV testing, plus extra support for those who …
Sponsor: University of Utah • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a Two-Vaccine strategy better shield spleenless patients from pneumonia?
Disease control CompletedThis trial investigates whether giving two different pneumonia vaccines—one followed by another a year later—boosts immune protection more than a single vaccine alone in adults who have had their spleen removed. People without a spleen are at higher risk for serious pneumococcal …
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Mobile clinic brings HIV treatment to the streets: Same-Day start could transform care for the excluded
Disease control CompletedThis study tests a new way to help vulnerable people with HIV get diagnosed and start treatment right away using a mobile screening unit. Participants receive the once-daily pill Biktarvy on the same day they are enrolled. The goal is to see if this approach helps them stay in ca…
Phase 4 • Sponsor: Fundacion SEIMC-GESIDA • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug naderin may help patients fight infections during cancer and TB therapy
Disease control CompletedThis study tested whether adding Naderin (sodium nucleinate) to standard treatment could reduce complications in 75 patients with cancer, tuberculosis, or hepatitis C. The main group received Naderin plus standard therapy, while the control group received standard therapy alone. …
Phase 2/3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
One-Stop health check: can integrated care tame HIV and heart disease together?
Disease control CompletedThis trial tests a package of services called TASKPEN, which combines HIV care with screening and treatment for high blood pressure, diabetes, and tobacco use. It involves over 5,700 adults living with HIV in Lusaka, Zambia. The goal is to see if this integrated approach helps mo…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Simple breathing and walking exercises may speed lung recovery after COVID-19 pneumonia
Disease control CompletedThis study investigates whether respiratory muscle training and walking exercises can improve lung function, reduce breathlessness, and enhance quality of life in women who have recovered from COVID-19 pneumonia. Eighty women aged 20 to 45 are divided into four groups: a combinat…
Sponsor: Hitit University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a blood pressure drug reverse liver damage in hepatitis c?
Disease control CompletedThis study tested whether adding prazosin, a drug usually used for high blood pressure, to standard hepatitis C treatment could reduce liver scarring. 112 adults with chronic hepatitis C (genotype 1 or 4) and severe liver fibrosis took part. Researchers measured changes in liver …
Phase 2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gut bacteria transplant shows promise for recurring UTIs
Disease control CompletedThis study tested whether transplanting healthy gut bacteria (washed microbiota transplantation) could help people who get frequent urinary tract infections (UTIs). Thirty adults with recurrent UTIs received the treatment through a tube into the gut. Researchers tracked how many …
Phase 1/2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Clotting clues: simple blood test eyed to catch sepsis before it turns deadly
Diagnosis CompletedResearchers want to know whether a bedside device that measures how blood clots can predict which patients with an infection will develop sepsis. The study enrolls 147 adults arriving at an emergency department with a suspected infection. Everyone gives blood for the clotting mon…
Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Diagnosis
Last updated Sep 21, 2026 19:00 UTC
-
New malaria test aims to catch hidden infections in pregnant women
Diagnosis CompletedMalaria in pregnancy often causes no symptoms, yet it can lead to anaemia, premature birth, and low birth weight. Standard rapid tests miss many of these quiet infections. Researchers are comparing a new high-sensitivity rapid diagnostic test with conventional tests in 930 pregna…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Breath test probes hidden link between bloating and gut bacteria
Diagnosis CompletedResearchers are studying whether small intestinal bacterial overgrowth (SIBO) is common in people with abdominal bloating or distension. Adults aged 18 to 70 with these symptoms take a breath test that measures hydrogen and methane in their exhaled air. The study aims to see how …
Sponsor: Shandong University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a rapid HIV test get people treated sooner?
Diagnosis CompletedResearchers are studying whether a point-of-care nucleic acid test can diagnose HIV faster than standard lab testing and help people get into care or prevention services sooner. The trial enrolls adults at a Seattle HIV clinic, including people living with HIV and those seeking t…
Sponsor: University of Washington • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a Finger-Prick blood test reveal hidden malaria in the placenta?
Diagnosis CompletedMalaria in pregnancy can hide in the placenta and harm both mother and baby, yet it often goes undetected. This study enrolls about 1,200 pregnant women in Africa to see whether malaria rapid diagnostic tests, blood smears, and PCR on maternal blood can accurately detect or predi…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Blood tests could replace painful spleen sampling for deadly parasite
Diagnosis CompletedVisceral leishmaniasis is a fatal parasitic disease if left untreated, and current methods to check whether treatment worked require invasive sampling of the spleen or bone marrow. Researchers at Gondar University Hospital in Ethiopia are evaluating blood-based immune and molecul…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
Diagnosis CompletedResearchers in Senegal are testing a new way to care for children under 15 who come to primary health clinics with fever or diarrhea. The strategy combines rapid tests for malaria, dengue, and strep A with a digital tool that suggests treatment based on symptoms and test results.…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a digital assistant help clinics catch dengue fever faster?
Diagnosis CompletedDengue fever is common in Burkina Faso, but primary health clinics often rely only on malaria rapid tests when a child arrives with fever. Researchers are testing a digital module that walks health workers through the country's dengue management guideline and pairs it with dengue…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Mailing hepatitis c tests home could reach people who avoid clinics
Diagnosis CompletedResearchers in Georgia are testing whether mailing hepatitis C self-tests to people who inject drugs and men who have sex with men increases how many get tested. The trial enrolls 1,250 adults in Tbilisi and Batumi who do not know their hepatitis C status. Half receive a self-tes…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Could a mouthwash replace a tube down your throat to diagnose pneumonia?
Diagnosis CompletedThis study tests whether a simple salt-water mouth rinse can detect pneumocystis, a lung infection that can be life-threatening in people with weak immune systems. Current diagnosis requires coughing up sputum or a tube inserted into the lungs, which can be uncomfortable. Researc…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Home hepatitis c tests could reach thousands in pakistan
Diagnosis CompletedResearchers in Karachi, Pakistan, are studying whether delivering hepatitis C self-tests to people's homes increases how many get tested. The trial enrolls about 2,000 adults who live in two areas of the Malir district and have not recently been tested. Half receive a self-test k…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can At-Home hepatitis c tests reach people clinics miss?
Diagnosis CompletedResearchers are testing whether giving people in Malaysia a rapid hepatitis C self-test kit to use at home increases how many get tested, compared with standard clinic-based testing. The trial enrolls 750 adults who are not known to have hepatitis C and have not been tested in th…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a new ultrasound device spot liver damage without a biopsy?
Diagnosis CompletedResearchers are testing the Liver Incyte system, an ultrasound device that measures how stiff the liver is, to see if it can tell healthy people apart from those with liver fibrosis or steatosis. The trial includes 140 adults, some healthy and some with a history of hepatitis C o…
Sponsor: Sonic Incytes • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Can lung ultrasound reveal COVID-19's signature in the lungs?
Diagnosis CompletedResearchers are studying whether lung ultrasound can reliably show the patterns of COVID-19 pneumonia in hospitalized patients. The trial enrolls adults admitted with confirmed COVID-19 and respiratory symptoms who need a chest CT scan. By comparing ultrasound images with CT scan…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Ultrasound could offer a clearer window into joint infections
Diagnosis CompletedResearchers are testing whether ultrasound can reliably show joint damage and inflammation in people with septic arthritis, a painful joint infection. The trial follows 28 adults with septic arthritis in the shoulder, elbow, wrist, hip, knee, or ankle. Participants receive standa…
Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Finger-Prick test could cut needless antibiotics in feverish toddlers
Diagnosis CompletedYoung children who arrive at the emergency department with a fever and no obvious cause often get blood tests and antibiotics just in case. Researchers are testing whether a rapid finger-prick procalcitonin test, combined with a set of clinical rules, can help doctors identify wh…
Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Could a neck vein check replace a harder ultrasound for ICU fluid management?
Diagnosis CompletedDoctors in the ICU need to know if a patient needs more fluids, and they often use ultrasound to check a large belly vein called the inferior vena cava. But that view can be hard to get. This study tests whether measuring a vein in the neck, the right internal jugular vein, works…
Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
A simple blood test may spot severe bacterial infections faster in the ER
Diagnosis CompletedResearchers in Basel are testing whether a blood marker called HNL can help emergency doctors quickly tell whether an infection is bacterial or viral. The study will enroll about 516 adults with suspected infection and signs of physiological disturbance. Doctors will measure HNL …
Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can COVID-19 rapid tests slip into HIV and TB clinics without disrupting care?
Diagnosis CompletedResearchers are studying whether adding rapid antigen testing for SARS-CoV-2 to HIV, maternal and child health, and tuberculosis clinics in Cameroon and Kenya increases the number of people tested and diagnosed with COVID-19. The study compares clinic activity before and after th…
Sponsor: Elizabeth Glaser Pediatric AIDS Foundation • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
A single swab, two diseases: rapid test takes on TB and COVID-19
Diagnosis CompletedResearchers are testing a portable device called Truenat MTB Plus/COVID-19 to see if it can accurately detect both tuberculosis and COVID-19 from the same sample. The study will enroll about 2,000 adults who have symptoms like a long-lasting cough, fever, or weight loss, which co…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
New rapid mpox tests could speed up diagnosis in remote areas
Diagnosis CompletedThis study will check how well three new rapid tests detect mpox virus compared to a standard lab test. Researchers will use about 80 stored skin swab samples from Uganda. The goal is to see if these quick, portable tests are accurate enough for use in places without full labs.
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
New tests aim to outsmart superbug gonorrhea
Diagnosis CompletedThis study is testing three new diagnostic tests to see if they can correctly identify a gene mutation that makes gonorrhea resistant to the antibiotic ciprofloxacin. Researchers will use leftover samples from over 3,000 people who already tested positive for gonorrhea. If the te…
Sponsor: Duke University • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Can newer tests match the gold standard for detecting Drug-Resistant TB?
Diagnosis CompletedThis study evaluates whether two newer line probe assays, the YD REBA MTB-MDR and Hain Genotype MTBDRplus V2, perform as well as the older Hain Genotype MTBDRplus V1 in detecting drug-resistant tuberculosis. Researchers will test stored, de-identified samples from adults with sym…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New rapid tests for respiratory infections put to the test in africa
Diagnosis CompletedThis study is testing new rapid tests (lateral flow and microfluidic devices) to detect respiratory infections in children and adults in Uganda, Ethiopia, and Senegal. Researchers want to see if these tests are accurate and easy to use in low-resource clinics. Participants with r…
Sponsor: Karolinska Institutet • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Can a 15-Minute test stop a deadly virus in its tracks?
Diagnosis CompletedThis trial evaluates a new rapid diagnostic test designed to detect Crimean-Congo hemorrhagic fever (CCHF) at the point of care. The test aims to provide results in minutes instead of the current 2-5 days, which could speed up treatment and reduce the risk of the disease spreadin…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Beyond TB: could a deeper diagnostic look uncover hidden lung diseases?
Diagnosis CompletedThis study tests whether an enhanced diagnostic workup can identify lung diseases other than tuberculosis in patients who are about to start TB treatment based on clinical signs but have negative sputum tests. Participants will undergo a thorough review and possibly additional te…
Sponsor: Stichting Longartsen voor Afrika • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
A radioactive 'Iron Magnet' could reveal hidden lung fungus
Diagnosis CompletedThis trial tests whether a new imaging tracer, gallium-68-deferoxamine, can make Aspergillus fungus infections in the lungs visible on a PET/CT scan. The study involves 10 adults with suspected chronic pulmonary aspergillosis or allergic bronchopulmonary aspergillosis. The goal i…
Phase 2 • Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Could a simple Self-Swab revolutionize cervical cancer screening?
Diagnosis CompletedThis trial tests whether a vaginal self-sampling device can accurately detect high-risk human papillomavirus (HPV) compared to samples collected by a clinician. About 1,000 women aged 30-64, either regular screening attendees or those who haven't been screened in 3+ years, will p…
Sponsor: AML • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Can a quick PCR test speed up lifesaving fungal infection diagnosis?
Diagnosis CompletedThis pilot study explores whether a PCR-based test can deliver faster results for diagnosing invasive candidiasis in intensive care patients. The trial compares the time to results using this new strategy against standard methods, with the hope of enabling earlier, more targeted …
Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Can a new blood test catch congenital toxoplasmosis earlier?
Diagnosis CompletedThis trial evaluates a new blood test (ELISPOT) that looks for immune cells in a newborn's cord blood that produce antibodies against the Toxoplasma parasite. The goal is to see if this test can diagnose congenital toxoplasmosis—an infection passed from mother to baby during preg…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
Tooth blood test could tell if a root canal is really needed
Diagnosis CompletedThis study looks at whether substances in the blood from a tooth's pulp can help dentists tell the difference between reversible pulpitis (a mild inflammation that can heal) and irreversible pulpitis (severe damage needing a root canal). Researchers will collect a small sample of…
Sponsor: Safa • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
A 5-hour test may replace days of waiting for the right antibiotic in blood infections
Diagnosis CompletedThis trial tests whether a rapid diagnostic test called Reveal can improve outcomes for hospitalized patients with gram-negative bloodstream infections. The test measures bacterial growth by detecting gases they release, giving results in about 5 hours instead of the usual 2-3 da…
Sponsor: Duke University • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
A dipstick test for joint infection? study puts cheap diagnostics to the test
Diagnosis CompletedThis study investigates whether three common lab tests — blood levels of ESR and CRP, plus a leukocyte esterase dipstick test on joint fluid — can reliably diagnose chronic infection in people who have had a total joint replacement. The researchers will compare the test results a…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New rapid test could free TB patients from isolation sooner
Diagnosis CompletedThis study evaluates a rapid viability test for tuberculosis bacteria in sputum samples. The goal is to see if this test can accurately tell whether a patient is still contagious, compared to the standard culture method that takes weeks. If the test works, it could help doctors d…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
New DNA test could revolutionize diagnosis of eye infections
Diagnosis CompletedThis study tested a new method called metagenomic deep sequencing (MDS) to find the cause of eye infections. 100 adults with suspected infectious uveitis or endophthalmitis were randomly assigned to have their doctors receive MDS results or not, in addition to standard tests. The…
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Urine test may predict kidney recovery in septic shock patients
Diagnosis CompletedThis study tested whether a urine test measuring two proteins (TIMP2 and IGFBP7) can tell which septic shock patients will recover normal kidney function within 72 hours. Researchers analyzed data from 77 patients in French ICUs. The goal is to help doctors decide who needs aggre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New swab test aims to spot COVID, flu, and RSV in minutes
Diagnosis CompletedThis study tested two new rapid tests that use a single nose swab to detect COVID-19, influenza A/B, and RSV. Researchers checked how accurate the tests are compared to standard lab methods and whether healthcare workers find them easy to use. The study involved 589 people with s…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New device aims to detect flu, RSV, and COVID-19 in one quick test
Diagnosis CompletedThis study collected nasal swabs, throat swabs, and saliva samples from 79 people with symptoms of flu, RSV, or COVID-19. The samples were used to help evaluate a point-of-care device called LumiraDx, which aims to quickly and accurately detect these viruses. The study focused on…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Which EBV test is most accurate? study puts three automated assays Head-to-Head
Diagnosis CompletedThis study compares three automated blood tests (Abbott Architect, Siemens Immulite, and Diasorin Liaison) for diagnosing Epstein-Barr virus (EBV) infection. Researchers analyzed 91 blood samples from patients aged 3 to 82 to see how well each test detects key markers of EBV infe…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Rapid COVID-19 test put to the test in Real-World clinics
Diagnosis CompletedThis study evaluates how well the LumiraDx SARS-CoV-2 Ag ULTRA test detects COVID-19 when used at point-of-care locations like clinics or pharmacies. Participants with COVID-19 symptoms provide nasal and nasopharyngeal swabs, and the test results are compared to a standard lab re…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple mouth rinse replace invasive tests for a deadly pneumonia?
Diagnosis CompletedThis study tested whether a simple mouth rinse could help diagnose Pneumocystis pneumonia, a serious lung infection in people with weakened immune systems. Researchers used a PCR test on the rinse sample to look for the fungus, aiming to find a threshold that indicates active inf…
Sponsor: Rennes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Fingerprick test could speed up detection of blood clots and infections
Diagnosis CompletedThis study tested whether a quick fingerstick blood test for D-Dimer (clot marker) and CRP (inflammation marker) gives the same results as standard lab tests using blood from a vein. Researchers enrolled 111 adults and compared results from fingerstick, venous whole blood, and pl…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Fingerprick COVID-19 antibody test put to the test
Diagnosis CompletedThis study checks whether a fingerstick blood test for COVID-19 antibodies gives the same results as standard lab tests using blood from a vein. About 42 people who recently had a positive COVID-19 PCR test will provide both fingerstick and venous blood samples. The goal is to se…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New rapid test for COVID-19 being developed with patient samples
Diagnosis CompletedThis study collected nose, throat, and blood samples from 523 adults with COVID-19 symptoms or a past positive test. The goal was to help develop and check the accuracy of a new rapid test for detecting COVID-19 antibodies and viral proteins. The test is designed to be used at th…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New rapid test could spot COVID and flu in minutes
Diagnosis CompletedThis study checked how well a new rapid test (LumiraDx) detects COVID-19 and flu A/B from a simple nose swab. Over 1,000 people with symptoms took part at clinics. The test aims to give fast results at the point of care, helping doctors tell these illnesses apart quickly.
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
New rapid test for infection and inflammation put to the test
Diagnosis CompletedThis study looked at how well a new, quick finger-prick test (LumiraDx CRP) measures CRP levels compared to a standard lab test. CRP is a marker of infection, inflammation, or tissue injury. 79 adults with symptoms of these conditions took part. The goal was to see if the new tes…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Rapid COVID and flu tests put to the test in real clinics
Diagnosis CompletedThis study checked how accurate two rapid tests (LumiraDx SARS-CoV-2 Ag Ultra and LumiraDx SARS-CoV-2 & Flu A/B) are at detecting COVID-19 and flu in people with symptoms. 716 participants provided nasal swabs at clinics. The results were compared to standard lab tests to measure…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New DNA method may spot hidden joint infections faster
Diagnosis CompletedThis study tested a new DNA-based technique called shotgun metagenomics to see if it can diagnose chronic infections in artificial joints better than standard lab cultures. Researchers took samples from 144 adults undergoing surgery for a suspected joint infection. The goal was t…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New rapid test could spot flu and RSV in minutes at your local clinic
Diagnosis CompletedThis study tested a new rapid test (LumiraDx Influenza A/B + RSV Test) that uses a nasal swab to quickly detect flu A, flu B, and RSV. Over 500 people with cold or flu-like symptoms took part. The test was performed by healthcare workers at point-of-care sites and compared to sta…
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Rapid COVID-19 test put to the test in Real-World clinics
Diagnosis CompletedThis study tested a quick COVID-19 antigen test called LumiraDx at various point-of-care sites, like clinics. Over 1,100 people with COVID-19 symptoms took part. The test's accuracy was compared to standard lab methods to see how well it detects the virus.
Sponsor: LumiraDx UK Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New saliva test could diagnose COVID-19 in under an hour
Diagnosis CompletedThis study tested a new saliva-based test for SARS-CoV-2 that gives results in less than an hour, without needing lab equipment. Researchers compared it to the standard PCR method using samples from 627 people, including healthcare workers and patients. The goal was to see if thi…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Simple blood test could slash antibiotic overuse for coughs and colds
Diagnosis CompletedThis study tested whether giving general practitioners a rapid C-reactive protein (CRP) test helps them decide when antibiotics are truly needed for patients with respiratory infections. 140 patients with symptoms like cough, fever, or sore throat took part. Doctors in the test g…
Sponsor: MSPU des 3 Provinces • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New french screening tool aims to catch eating disorders in athletes early
Diagnosis CompletedThis study is adapting and testing a French version of the Athletic Disordered Eating (ADE) scale, a 17-question screening tool designed specifically for athletes. Researchers will enroll 229 athletes aged 15 to 70 who exercise more than 6 hours per week. Participants complete th…
Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New pill may stop COVID-19 after exposure – trial underway
Prevention CompletedThis study tests whether a pill called mitoquinone can prevent COVID-19 in healthy adults who have had close contact with someone who has COVID-19. About 112 participants will receive either the pill or a placebo. The goal is to see if it stops infection and reduces symptoms.
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Sep 21, 2026 19:00 UTC
-
UV water treatment tested to keep kids healthy
Prevention CompletedThis study tested whether treating private well water with ultraviolet (UV) light can prevent stomach and respiratory infections in children under 5. Researchers gave 28 Pennsylvania households either a real UV device or a fake one and tracked illness symptoms via weekly texts. T…
Sponsor: Temple University • Aim: Prevention
Last updated Sep 21, 2026 19:00 UTC
-
New mRNA flu shots enter human testing – could they beat the old ones?
Prevention CompletedThis study tests several new mRNA-based flu vaccines in about 971 healthy adults aged 18 and older. The goal is to see how well they trigger an immune response and how safe they are compared to standard flu shots. Participants receive one dose of an experimental vaccine or a comp…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Your phone could be the nudge that gets you vaccinated
Prevention CompletedResearchers test whether short messages sent through a mobile wellness app can increase flu vaccination rates among insured adults. The messages, delivered as push notifications and in-app posts, either highlight incentives or use generic wording. The study compares vaccination r…
Sponsor: Evidation Health • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can school lessons boost teen vaccine uptake?
Prevention CompletedResearchers compare one French middle school that used the e-Bug educational programme with other schools in the region to see whether classroom lessons about vaccination relate to higher HPV and meningococcal ACWY vaccine coverage. The study uses only aggregated, anonymised vacc…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can Same-Day HIV prevention reach people before infection takes hold?
Prevention CompletedResearchers are testing a field-based sexual health program for people recently exposed to HIV who were notified by New York City's partner services program. The program adds four services to standard contact tracing: HIV and STI testing in the field, same-day start of HIV preven…
Sponsor: Hunter College of City University of New York • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can a behavior change program cut hospital infections in southeast asia?
Prevention CompletedHospital-acquired infections are a major problem in low- and middle-income countries. Researchers are developing and piloting an infection prevention and control program for healthcare workers in Cambodia and Laos. The program aims to improve hand hygiene and equipment disinfecti…
Sponsor: National University of Singapore • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a daily antiseptic bath keep central lines safer for sick kids?
Prevention CompletedCritically ill children with central venous catheters face a risk of bloodstream infections that can lead to longer hospital stays and serious complications. Researchers are testing whether bathing these children daily with a 2% chlorhexidine gluconate solution prevents central l…
Sponsor: Istanbul Medeniyet University • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a pill stop COVID-19 before it starts?
Prevention CompletedResearchers are testing whether an antiviral tablet called S-217622 can prevent symptomatic COVID-19 in people who live with someone who has symptoms. The trial enrolls household contacts of a person with symptomatic COVID-19 and gives them either the antiviral or a placebo for a…
Phase 3 • Sponsor: Shionogi • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Could a 5-Minute nasal light zap stop surgical infections?
Prevention CompletedThis completed trial tested a device that uses light to kill germs in the nose before surgery, aiming to prevent surgical site infections. Over 400 adults having major surgeries received either the light treatment or standard care. Researchers tracked infections and side effects …
Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Nasal light zaps infection risk before surgery
Prevention CompletedThis study tested a new way to prevent surgical site infections by using a special light treatment inside the nose just before surgery. Over 4,700 adults having major surgeries like heart, spine, or joint replacement took part. The goal was to see if this light therapy reduces in…
Phase 3 • Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Which antibiotic cocktail best shields vascular surgery patients from MRSA?
Prevention CompletedResearchers are comparing two antibiotic combinations given before vascular surgery to see which better prevents MRSA infections. Adults scheduled for procedures such as carotid surgery or dialysis access creation receive either vancomycin plus cefazolin or daptomycin plus cefazo…
Sponsor: CAMC Health System • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Smallpox drug put to the test in healthy volunteers
Prevention CompletedResearchers are testing an antiviral drug called tecovirimat to see if it is safe and well tolerated when taken by mouth for 14 days. The trial enrolls healthy adults aged 18 to 80 and compares tecovirimat with a placebo. The goal is to gather safety information that could suppor…
Phase 3 • Sponsor: SIGA Technologies • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Smallpox drug put to the test: can TPOXX be taken safely for a month?
Prevention CompletedResearchers are studying whether an antiviral drug called tecovirimat (TPOXX) is safe and well tolerated when taken by mouth twice daily for 28 days. The trial enrolls healthy adults aged 18 to 80 and compares TPOXX with a placebo. The main goal is to measure drug levels in the b…
Phase 3 • Sponsor: SIGA Technologies • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Antiviral tecovirimat put to the test for smallpox threat
Prevention CompletedResearchers tested two doses of tecovirimat, an antiviral drug, in healthy volunteers to see how safe and well-tolerated it is. Participants took a daily oral dose for 14 days, and researchers monitored side effects and measured drug levels in the blood. The goal was to find the …
Phase 2 • Sponsor: SIGA Technologies • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Can a community education push get more people tested and vaccinated for COVID-19?
Prevention CompletedResearchers test whether a community-based health education program helps Hong Kong residents get tested early for COVID-19, accept vaccination, and follow self-protection measures like hand washing and mask wearing. The trial enrolls about 1,200 residents, including adults and s…
Sponsor: The Hong Kong Polytechnic University • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Can a caregiver app stop pressure sores before they start?
Prevention CompletedResearchers at Akdeniz University are testing Care-Up, a mobile-friendly web tool that gives family caregivers structured guidance on skin care, pressure-injury prevention, urinary-risk signs, nutrition, hydration, and when to call a professional. The trial enrolls 66 patient-car…
Sponsor: Akdeniz University • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
The order of a text message may decide whether someone gets a COVID test
Prevention CompletedResearchers in St. Louis are studying whether the order of offers in a text message changes how people respond to COVID-19 testing and vaccination help. Participants are adults applying for rent or utility assistance in St. Louis City or County. Each person gets a survey with two…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Can HIV-Positive mothers breastfeed without passing the virus to their babies?
Prevention CompletedResearchers follow more than 1,200 HIV-positive pregnant and postpartum women in Kigali, Rwanda, who receive standard HIV care through prevention of mother-to-child transmission programs. The study tracks whether their babies remain HIV-free through 18 to 24 months of age while m…
Sponsor: Elizabeth Glaser Pediatric AIDS Foundation • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Can a phone call keep HIV-Positive mothers and babies on track?
Prevention CompletedThis trial tests whether mobile phone communication helps HIV-positive pregnant women in Kenya complete the steps that prevent passing HIV to their babies. Twenty-six health facilities are assigned to either standard care or standard care plus phone-based support for mothers, mal…
Sponsor: Elizabeth Glaser Pediatric AIDS Foundation • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
New rectal gel could offer On-Demand HIV protection without daily pills
Prevention CompletedThis study tests two ways to prevent HIV: a rectal gel used before sex and daily pills. About 150 men will try each method for 8 weeks to see which is safer, easier to use, and more acceptable. The goal is to give people more choices for on-demand HIV prevention.
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Lab-Made antibodies put to the test as HIV prevention for women
Prevention CompletedResearchers are testing two lab-made antibodies, CAP256V2LS and VRC07-523LS, given as shots under the skin to young women who do not have HIV. The phase II trial enrolls about 990 women aged 18 to 30 in Zambia and nearby countries. It measures whether the shots cause serious reac…
Phase 2 • Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can peer coaches boost HIV prevention in latina trans women?
Prevention CompletedResearchers at George Washington University are testing a program called Juntas Adelante to see if it helps Latina transgender women in the Washington DC area learn about and use HIV prevention medicines. The program includes five short online videos and up to two virtual coachin…
Sponsor: George Washington University • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can a single therapy session help prevent HIV in people facing homelessness?
Prevention CompletedResearchers at the University of Washington are adapting a brief narrative therapy session for use in a low-barrier primary care clinic that serves people experiencing homelessness in North Seattle. The study enrolls 64 adults who have had at least one therapy appointment at the …
Sponsor: University of Washington • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can a phone app boost HIV prevention in thai youth?
Prevention CompletedThis study is testing a computer-based program called MES-PrEP to help young transgender women in Thailand start and stick with HIV pre-exposure prophylaxis (PrEP). The program provides personalized feedback and information based on each person's confidence and motivation. Resear…
Sponsor: University of Massachusetts, Worcester • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple preventive drug cut malaria and anemia in infants?
Prevention CompletedThis trial tests whether giving infants a preventive dose of the antimalarial drug sulfadoxine-pyrimethamine during routine health visits can lower their risk of malaria and anemia. Researchers will follow about 2,100 children in Cameroon, comparing those in areas receiving this …
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Can scheduled malaria drugs shield infants from severe illness?
Prevention CompletedThis trial tests whether giving infants in Côte d'Ivoire a preventive dose of an antimalarial drug at routine health visits can lower their risk of malaria and anemia. Researchers will compare outcomes for infants in areas receiving this intervention against those receiving stand…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Cranberry juice: a UTI shield for some women?
Prevention CompletedThis study explores why cranberries prevent urinary tract infections (UTIs) in some women but not others. Researchers will test the urine of 55 healthy women before and after drinking cranberry juice to see if it stops bacteria from sticking to the bladder. The goal is to identif…
Sponsor: University of Florida • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Vietnam tests chat and text to boost flu shots for seniors
Prevention CompletedThis study tests whether a community-based communication program can increase flu vaccination rates among people over 65 in Can Tho City, Vietnam. The program includes direct counseling, weekly health tips via the Zalo app, and printed leaflets. Researchers will compare vaccinati…
Sponsor: Can Tho University of Medicine and Pharmacy • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Can a stronger flu shot boost immunity in older adults?
Prevention CompletedThis trial tests three flu vaccines in adults aged 65 and older: a standard dose, one with an adjuvant to boost response, and a high-dose version. Researchers measure antibody levels and immune cell activity to see which vaccine triggers the strongest protection. They also examin…
Phase 4 • Sponsor: Korea University Guro Hospital • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
New malaria prevention combo tested in mali infants
Prevention CompletedThis study tests the safety of an experimental medicine called L9LS in infants aged 1 to 12 months in Mali. It also looks at how L9LS affects the immune response to a malaria vaccine called R21/Matrix-M. The goal is to find a better way to prevent malaria in young children.
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Can four group sessions teach safer habits to injection drug users?
Prevention CompletedResearchers are testing whether a four-week group program can help people who inject drugs and are in methadone treatment reduce their risk of HIV. The program teaches skills like cleaning needles and using condoms, and it is compared with a support group that does not focus on t…
Sponsor: University of Connecticut • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
New flu vaccine shows promise for seniors in massive trial
Prevention CompletedThis large study tested whether an enhanced flu vaccine (Fluad) works better than standard flu shots in adults aged 65 and older. Over 38,000 participants received either Fluad or a regular vaccine. The goal was to see if Fluad prevents confirmed flu cases more effectively. Resul…
Phase 3 • Sponsor: Seqirus • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
A simple idea to stop STIs: send treatment home with the patient
Prevention CompletedThis trial tests a strategy called expedited partner therapy (EPT) for men who have sex with men in Peru. When a participant is diagnosed with gonorrhea or chlamydia, they receive antibiotic packets to give to their recent sexual partners, so those partners can get treated withou…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Can a Lab-Made antibody outperform standard tetanus shots?
Prevention CompletedThis phase 3 trial compares a new lab-made antibody, TNM002, with the standard human tetanus immunoglobulin for preventing tetanus in adults with dirty or contaminated wounds. Participants receive one injection of either treatment, and researchers measure whether their blood reac…
Phase 3 • Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Extra vaccine dose: could it shield dialysis patients from hepatitis b?
Prevention CompletedThis trial asks whether giving dialysis patients four doses of a double-strength hepatitis B vaccine offers better protection than the standard three doses. People with kidney failure on dialysis often respond weakly to vaccines, leaving many unprotected. The study will compare a…
Sponsor: Jinnah Hospital • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Can a simple antibody infusion shield kidney transplants from a sneaky virus?
Prevention CompletedThis study tested whether giving intravenous immunoglobulins (IVIG) could prevent BK virus infection in kidney transplant recipients. The virus often causes graft problems. Researchers enrolled 359 patients with low antibody levels against their donor's virus strain and gave some…
Phase 4 • Sponsor: University Hospital, Strasbourg, France • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Can a friendly welcome cut HIV rates among migrants?
Prevention CompletedThis trial tests whether a community-based program can help reduce HIV infections among people who move into rural Ugandan communities. Migrants often have higher HIV rates but are less likely to use prevention and care services. The program, called WIN, trains community voluntee…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Can a family workshop curb sexual risks in latina teens?
Prevention CompletedThis trial tests a workshop called Floreciendo, designed for Latina teens aged 14-18 and their female caregivers. The workshop covers sexual health basics, condoms and contraception, family communication, and gender relationships. The study aims to see if the program is feasible …
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
Texting parents could be key to curbing HPV-Related cancers
Prevention CompletedThis trial tests whether text messages to parents and a brief training for healthcare providers can increase HPV vaccination rates among 11- and 12-year-olds. The study involves over 8,000 adolescents and their parents across Florida clinics. Some clinics will use both interventi…
Sponsor: University of Florida • Aim: Prevention
Last updated Aug 06, 2026 00:00 UTC
-
Can a Father-Focused program curb HIV, substance abuse, and violence?
Prevention CompletedThis trial tests a program designed for Latino fathers to help them reduce risky sexual behaviors, substance abuse, and domestic violence, and improve communication with their sons. The program combines two behavioral interventions: one that teaches fathers about HIV prevention a…
Sponsor: University of Miami • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Walking groups could shield HIV-Positive latino men from heart disease
Prevention CompletedThis study tests a culturally tailored program to prevent chronic diseases like diabetes, high blood pressure, and obesity in Latino men over 50 living with HIV. Participants meet with a community health worker, join group walking sessions three times a week, and discuss pleasant…
Sponsor: University of Miami • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Friends helping friends: a novel social-network strategy to boost HIV prevention
Prevention CompletedThis study tests whether training influential members of social networks to talk about PrEP can encourage more African-American men who have sex with men to use it. Half of the recruited networks will have their leaders trained to share accurate PrEP information and counter misco…
Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Could a cup of tea prevent pneumonia in ICU patients?
Prevention CompletedThis study tests whether mouth care with green tea or white tea can prevent ventilator-associated pneumonia (VAP) as well as the standard antiseptic chlorhexidine. It includes adults in intensive care who are on breathing machines. The goal is to see if these natural alternatives…
Sponsor: Recep Tayyip Erdogan University • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedThis trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial…
Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New antibody shot aims to shield vulnerable patients from COVID-19
Prevention CompletedThis study tested an experimental antibody called AZD3152 to see if it can safely prevent COVID-19 in people with weakened immune systems. About 3,882 adults received either the antibody or a placebo/comparator. The goal was to measure how well the antibody neutralizes the virus …
Phase 2/3 • Sponsor: AstraZeneca • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Brainwave device may ease stress for healthcare workers
Symptom relief CompletedThis study tested a device called Cereset Research that plays tones in response to a person's brainwaves, aiming to reduce stress and improve sleep. 94 stressed healthcare workers used the device for several sessions and were followed for a year. The goal was to see if the device…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Sep 21, 2026 19:00 UTC
-
Herbal supplement cistanche tested for explosive power and recovery in athletes
Symptom relief CompletedThis study tested whether taking a cistanche supplement for 8 weeks, along with a supervised training program, improves anaerobic exercise performance and recovery in young men. 56 men aged 18-25, either elite or amateur athletes, were randomly assigned to receive cistanche extra…
Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Sep 21, 2026 19:00 UTC
-
Can a common antioxidant shield kidneys from leptospirosis?
Symptom relief CompletedResearchers are testing whether oral N-acetylcysteine (NAC) can reduce signs of kidney tubular injury, oxidative stress, and inflammation in adults with non-severe leptospirosis. The trial enrolls 64 adults who have had fever for three to five days and a confirmed Leptospira infe…
Phase 2 • Sponsor: Dr Cipto Mangunkusumo General Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can tilting a Patient's body toward the infection help them breathe free sooner?
Symptom relief CompletedResearchers are testing whether adjusting a patient's body position based on where the lung infection sits, combined with mechanical vibration on the chest, helps clear infected mucus better than routine position changes. The trial enrolls 384 adults in intensive care who need a …
Sponsor: Affiliated Hospital of Jiangnan University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a home exercise program help long COVID patients take back control?
Symptom relief CompletedResearchers are testing whether a 12-week online rehabilitation program helps people with long COVID manage their own health, fatigue, and quality of life. The program combines personalized exercise with education sessions and a mobile app for daily tracking. Participants attend …
Phase 2 • Sponsor: CEU San Pablo University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Chilling dental anesthetic may cut root canal pain
Symptom relief CompletedResearchers are testing whether cooling local anesthetic before injecting it into the tooth's pulp reduces pain during root canal treatment. The trial enrolls 40 people with painful, inflamed lower molars who need a root canal. Each participant receives the anesthetic at either c…
Sponsor: Gulf Medical University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Which root canal file leaves less pain? trial puts two systems to the test
Symptom relief CompletedResearchers compare two root canal file systems, ProTaper Gold and ProTaper Ultimate, to see if they differ in how much pain patients feel afterward. The trial enrolls 40 adults with permanent lower molars diagnosed with symptomatic irreversible pulpitis and apical periodontitis.…
Sponsor: Gulf Medical University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Cold and vibration may replace numbing cream for Kids' shots
Symptom relief CompletedShots and blood draws cause pain and anxiety in children, and numbing creams take time to work. Researchers are testing a device that uses cold, vibration, and distraction to block needle pain. The trial compares this device with standard numbing cream in children aged 4 to 15 at…
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Which root canal sealer leaves patients in less pain?
Symptom relief CompletedResearchers compare three sealers used during root canal treatment, Totalfil, NeoSealer, and AH-Plus, to see how much pain patients feel afterward. The study includes 39 people with painful, inflamed lower molars that need a root canal. Each participant receives one of the three …
Sponsor: Gulf Medical University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Which dental filling material keeps molars alive and Pain-Free?
Symptom relief CompletedResearchers compare two materials used in pulpotomy, a procedure that removes inflamed pulp from a tooth and covers the remaining tissue. Adults with deep cavities and signs of pulp inflammation in lower first or second molars receive either BIO MTA+ or Well-Root PT. The study me…
Phase 4 • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Magnetic pulses may ease Post-Polio symptoms
Symptom relief CompletedThis study tested whether adding transcranial magnetic stimulation (TMS) to standard exercise can reduce fatigue, pain, and improve walking in people with postpolio syndrome. 26 adults who had polio earlier in life and now have new symptoms took part. Half got TMS plus exercise, …
Sponsor: Ege University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a single therapy session ease depression in HIV care?
Symptom relief CompletedThis pilot study tests whether a single session of narrative therapy, a type of talk therapy, can help reduce depression and anxiety in people living with HIV. Researchers will enroll 64 adults from a primary care HIV clinic to see if the therapy is acceptable, feasible, and bene…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Jaw pain relief? PRP and hyaluronic acid injections show promise in small study
Symptom relief CompletedThis study tested a combination of platelet-rich plasma (PRP) from the patient's own blood and hyaluronic acid injected into the jaw joint. Twenty-two adults with painful clicking and limited mouth opening received the treatment. Researchers used a jaw tracking device to measure …
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Heart failure hope: Anti-Inflammatory drug may reduce need for dangerous heart meds
Symptom relief CompletedThis early-phase study tests whether anakinra, a drug that blocks inflammation, can make the heart more sensitive to inotropes (medicines that strengthen heart contractions) in people with end-stage heart failure. If successful, patients might need lower, safer doses of inotropes…
Phase 1 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New resilience program aims to boost mental strength in aging HIV patients
Symptom relief CompletedThis study tested a resilience-building program called RISE+ in 106 people over 50 living with HIV. Participants watched videos and did activities to improve coping skills, optimism, and social connections. The goal was to see if the program helps them handle daily stress better …
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a local anesthetic stop shingles pain from becoming chronic?
Symptom relief CompletedThis trial tests whether injecting lidocaine under the skin at the shingles rash site can reduce pain and help prevent post-herpetic neuralgia, a long-lasting nerve pain that can follow shingles. Adults with acute shingles pain or established post-herpetic neuralgia will receive …
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Root canal pain relief: does adding NSAIDs to paracetamol help?
Symptom relief CompletedThis study looked at how well paracetamol alone or combined with different NSAIDs (ibuprofen, mefenamic acid, or diclofenac) controls pain after root canal treatment. 185 adults with severe tooth pain took part. The goal was to see if combining drugs works better than paracetamol…
Phase 2 • Sponsor: University of Khartoum • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can talking it out ease PTSD in cancer patients during a pandemic?
Symptom relief CompletedThis study tested whether monthly 45-minute psychological interviews over 6 months could reduce post-traumatic stress symptoms in cancer patients affected by the COVID-19 pandemic. It included 29 adults with solid tumors who had moderate to high PTSD symptoms. The goal was to see…
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Can a Couple's online Self-Help program heal COVID-19 PTSD?
Symptom relief CompletedThis trial tests whether an internet-based self-help program called Couple HOPES can reduce PTSD symptoms and improve relationship satisfaction in couples where one partner is a military member, veteran, first responder, or healthcare worker with COVID-19-related PTSD. Participan…
Sponsor: York University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could a simple injection make root canals less painful?
Symptom relief CompletedThis trial tests whether a corticosteroid injection given before root canal treatment can reduce pain and inflammation afterward. One hundred adults with symptomatic pulpitis (tooth nerve inflammation) are randomly assigned to receive either standard root canal treatment alone or…
Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Could a painkiller stop the cough that Won't quit in lung fibrosis?
Symptom relief CompletedThis study tested whether an extended-release form of nalbuphine, a pain medication, can reduce chronic coughing in people with idiopathic pulmonary fibrosis (IPF). 165 participants received either different doses of the drug or a placebo for 6 weeks. The main goal was to see if …
Phase 2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Did pandemic precautions lower fungal infections? hospital records hold clues
Knowledge-focused CompletedResearchers reviewed hospital records from 1,441 patients to compare fungal infection rates during the SARS-CoV-2 pandemic and afterward. They calculated positivity rates for Candida and Aspergillus species and other fungi. The study examines whether infection control measures ch…
Sponsor: Bekir Sami Uyanık • Aim: Knowledge-focused
Last updated Sep 21, 2026 19:00 UTC
-
Can a chatbot get more men tested for HIV?
Knowledge-focused CompletedThis study will test whether an artificial intelligence chatbot can encourage men who have sex with men in Kuala Lumpur, Malaysia to get tested for HIV. 80 participants will be randomly assigned to receive either automated chatbot messages with HIV testing information or standard…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 21, 2026 19:00 UTC
-
Blood samples and health records could reveal why some COVID-19 cases turn severe
Knowledge-focused CompletedResearchers in the Ile-de-France region are following adults hospitalized with COVID-19 or suspected of having it. They collect blood samples at admission and, for severe cases, at several later points, and they track health outcomes over time. The goal is to identify which facto…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Sep 21, 2026 19:00 UTC
-
Does COVID-19 vaccination reduce deaths and hospital stays in care homes?
Knowledge-focused CompletedResearchers are comparing serious health events, such as death and unplanned hospital stays, between elderly residents of retirement homes and long-term care units who received a COVID-19 vaccination and those who did not. The study includes about 3,300 residents in the Ile-de-Fr…
Sponsor: Gérond'if • Aim: Knowledge-focused
Last updated Sep 21, 2026 19:00 UTC
-
NIH scientists probe immune secrets behind flu vaccines
Knowledge-focused CompletedThis study aimed to understand how the immune system responds to seasonal and H1N1 flu vaccines in healthy adults. Researchers collected blood and nasal samples from 203 NIH employees before and after vaccination. The goal was to analyze immune responses to improve future vaccine…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused CompletedThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Hidden hepatitis d: nationwide survey maps its reach in thailand
Knowledge-focused CompletedResearchers are surveying people in Thailand who have chronic hepatitis B to find out how many also carry hepatitis D, a virus that can make liver disease worse. The study focuses on groups at higher risk, including people who inject drugs, men who have sex with men, prisoners, a…
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into mysterious kidney scarring
Knowledge-focused CompletedThis completed study looked at why some people develop scarring in their kidneys, including rare diseases like FSGS and a mysterious form of chronic kidney disease affecting farm workers. Researchers collected blood, urine, and kidney tissue from 537 participants to better unders…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track dengue in kids to stop Mosquito-Borne illness
Knowledge-focused CompletedThis study followed 775 healthy children aged 2-9 in Cambodia over three years to learn how mosquitoes spread dengue and other viruses. Researchers took blood samples every wet and dry season to check for past or current infections. The goal was to understand why young children g…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Why does dengue put some people in the hospital? scientists track 258 patients to find out
Knowledge-focused CompletedDengue has become a recurring illness on Reunion Island, and repeat infections tend to be more severe. Researchers are following 258 adults and children who arrive at two island hospitals with confirmed or suspected dengue, collecting blood samples and health questionnaires over …
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Gut bacteria may worsen liver disease – new study investigates
Knowledge-focused CompletedThis study looked at how bacteria from the gut might travel to the liver and make liver disease worse in people with hepatitis C. Thirty adults with stable liver disease took part. Researchers used blood tests, MRI scans, and liver tissue samples to measure bacterial movement and…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tiny study hopes to unlock why pollution hurts some lungs more
Knowledge-focused CompletedThis completed study looked at how genetic differences might change the way immune cells in the lungs respond to environmental triggers like dust and germs. Researchers collected blood and lung samples from 20 healthy adults to compare cell function between people with different …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Hidden hepatitis e threat in transplant patients?
Knowledge-focused CompletedThis study checked how many organ transplant recipients in the U.S. have antibodies to the hepatitis E virus, which can become chronic in people with weakened immune systems. Researchers enrolled 447 adults who had a liver, kidney, or small bowel transplant or were on a waiting l…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Liberia's HIV epidemic under the microscope: major study completed
Knowledge-focused CompletedThis study followed 1,377 people living with HIV in Liberia over three years to track how the disease progresses and affects their health. Researchers collected blood and urine samples, conducted physical exams, and asked about medications and risk behaviors. The goal was to gath…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Free medicine at home could save thousands of kids from deadly diarrhea
Knowledge-focused CompletedThis study in Bauchi, Nigeria, is testing whether giving free Oral Rehydration Salts (ORS) and zinc directly to homes can increase how often these treatments are used for children under 5 with diarrhea. Over 100,000 children are taking part, with some areas receiving the medicine…
Sponsor: RAND • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
HIV meds may stir up herpes: new study investigates
Knowledge-focused CompletedThis study looked at 190 HIV-positive women starting HIV medicines to see how often herpes virus symptoms appear or get worse. Researchers collected blood, urine, and vaginal samples over a year to track virus activity. The goal was to understand why some women have herpes flare-…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Speedy bug ID: new tests aim to cut antibiotic guesswork in ICU blood infections
Knowledge-focused CompletedThis study tested whether three new diagnostic tools could help doctors pick the best antibiotic faster for ICU patients with Gram-negative bloodstream infections. Researchers compared standard lab methods to the new tests in 100 patients. The goal was to see if more patients got…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Anthrax secrets revealed: new study tracks infection and vaccine response
Knowledge-focused CompletedThis study follows people who have or had anthrax, those exposed, and healthy vaccinated volunteers to learn how the body fights the disease. Researchers will track symptoms, immune responses, and long-term health for up to 2 years. The goal is to better understand anthrax and im…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Blood donors help unlock secrets of hepatitis c
Knowledge-focused CompletedThis study looked at 805 blood donors who tested positive for hepatitis C virus (HCV) to learn how the virus spreads and affects health over time. Researchers collected blood samples and health information to track infection and liver disease. The goal was to better understand HC…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Two cheap blood ratios put to the test as sepsis death predictors
Knowledge-focused CompletedSepsis and septic shock cause organ failure and death, and doctors need simple ways to flag the patients most at risk. Researchers at Benha University Hospital followed 60 adults with sepsis or septic shock in a surgical intensive care unit for 28 days. They compared two ratios c…
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Massive study reveals real cancer risk for HPV-Positive women with mild pap smears
Knowledge-focused CompletedThis study followed over 46,000 women in the Netherlands who tested positive for HPV and had mild abnormal Pap results. Researchers tracked how many developed cervical cancer within five years. The goal was to see if these women could safely have fewer follow-up tests, making scr…
Sponsor: Gynaecologisch Oncologisch Centrum Zuid • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
COVID-19's hidden toll: muscle wasting in the ICU
Knowledge-focused CompletedResearchers at the University of Malaya are studying how COVID-19 affects muscle loss and strength in critically ill patients. They will compare quadricep muscle thickness and cross-sectional area, along with handgrip and knee extension strength, between COVID-19 and non-COVID-19…
Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study aims to reduce infections after esophagus cancer surgery
Knowledge-focused CompletedThis study reviews medical records of 350 adults who had surgery for esophageal cancer in France between 2017 and 2024. Researchers want to understand how often infections happen after surgery, what causes them, and how they affect recovery. The goal is to find ways to prevent th…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
Knowledge-focused CompletedThis study follows people treated for anal cancer with radiotherapy to see how their sexual quality of life changes over time. Participants complete questionnaires during treatment, three months later, and two years after diagnosis. The goal is to understand the long-term impact …
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can a Five-Minute reading shift food choices and ease loneliness?
Knowledge-focused CompletedResearchers at Jacobs University Bremen are running a three-phase study to understand how environmentally friendly behaviors relate to eco-anxiety, well-being, and loneliness. About 1,684 adults complete surveys about their food choices, consumption habits, and feelings of social…
Sponsor: Jacobs University Bremen gGmbH • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Mosquito bites as a research tool: can scientists reproduce malaria infection on demand?
Knowledge-focused CompletedResearchers in Lambaréné, Gabon, want to see if they can safely and reliably infect healthy adult volunteers with malaria using bites from local Anopheles gambiae mosquitoes carrying a local strain of Plasmodium falciparum. The team raises the mosquitoes in the lab, feeds them ma…
Phase 1 • Sponsor: Centre de Recherche Médicale de Lambaréné • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can viral markers predict who survives hepatitis b liver failure?
Knowledge-focused CompletedThis observational study follows people with hepatitis B-related acute-on-chronic liver failure who receive one of three antiviral drugs: entecavir, tenofovir alafenamide, or tenofovir amibufenamide. Researchers measure two newer virological markers, HBV RNA and HBcrAg, over time…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
COVID-19's hidden toll on black women: new study seeks answers
Knowledge-focused CompletedThis study asks over 1,600 African American women aged 23-35 about their experiences during the COVID-19 pandemic. Participants fill out a short online or paper survey covering infection, vaccination, childcare, job loss, and emotional stress. The goal is to understand how the pa…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Could a COVID-19 shot boost cancer immunotherapy? a massive study digs into the timing.
Knowledge-focused CompletedThis large observational study looks at whether getting an mRNA COVID-19 vaccine shortly before or after starting immune checkpoint inhibitor therapy is linked to longer survival in adults with cancer. Using data from nearly 100,000 patients in France, researchers are comparing t…
Sponsor: Groupe Hospitalier Pitie-Salpetriere • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Neighborhood chats may help overcome COVID-19 testing mistrust
Knowledge-focused CompletedThis study tested whether weekly community-led group discussions about health topics could change how people feel about COVID-19 testing and vaccines. 49 adults from housing authority agencies took part in Zoom meetings and completed surveys over 18 weeks. The goal was to see if …
Sponsor: Old Dominion University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Dengue Vaccine's Real-World safety under the microscope
Knowledge-focused CompletedResearchers are reviewing safety reports from people who received the Qdenga dengue vaccine at private vaccination centers in Buenos Aires. The review covers reports collected during the 2023 and 2024 dengue seasons. The goal is to see how often side effects were reported after v…
Sponsor: Fundación Vacunar • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can tracking antibiotic levels in the blood improve sepsis care?
Knowledge-focused CompletedThis study is tracking how the antibiotic ceftazidime-avibactam behaves in the blood of critically ill patients with severe sepsis. Researchers are collecting blood samples at several time points to measure drug levels and build a model that could help doctors choose the right do…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists probe COVID-19's attack on immune cells
Knowledge-focused CompletedThis study looked at how the virus that causes COVID-19 reduces the number of infection-fighting white blood cells (lymphocytes) in the blood. Researchers collected blood samples and medical records from 240 adults with or recovering from COVID-19. The goal was to learn more abou…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
HIV drug data dive: what happens when young patients take darunavir or etravirine?
Knowledge-focused CompletedResearchers are collecting health records from young people with HIV in ten African countries who have taken the drugs darunavir, etravirine, or both. The study follows their demographics, clinical and laboratory profiles, and HIV drug resistance over time. The goal is to underst…
Sponsor: Elizabeth Glaser Pediatric AIDS Foundation • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Joint infection study asks: how much does it cost your daily life?
Knowledge-focused CompletedProsthetic joint infections are rare but serious, often causing long hospital stays and lasting disability. Researchers at a French hospital are asking adults with these infections to fill out standard quality-of-life questionnaires during their regular follow-up visits. The stud…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can a new turkish questionnaire measure menstrual knowledge in athletes?
Knowledge-focused CompletedThis study aims to adapt the Menstrual Cycle Knowledge Questionnaire (MCKQ) into Turkish and check whether it is a valid and reliable tool for female athletes. Researchers will ask 120 women aged 16 to 35 who are licensed athletes to fill out the questionnaire, along with other s…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists dig deep into HIV: tissue biopsies reveal hidden clues
Knowledge-focused CompletedThis study collected tissue samples from the tonsils, lymph nodes, bowel, and lungs of HIV patients and healthy volunteers. The goal was to measure the amount of virus and certain immune cells in these tissues during treatment. By comparing samples, researchers hoped to learn mor…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gut feeding vs. IV: which saves more lives in the ICU?
Knowledge-focused CompletedThis study looked at whether giving nutrition through a tube into the stomach (enteral) or through a vein (parenteral) early on affects survival in very sick patients who need a breathing machine and heart-support medications. Over 2,400 adults in intensive care units were random…
Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
At-Home COVID-19 vaccine study could change how trials are done
Knowledge-focused CompletedThis study looks at whether people can reliably collect their own blood and saliva samples at home to measure how well COVID-19 vaccines work. About 4,000 adults who recently got a COVID-19 vaccine will either do everything remotely or visit a clinic. Researchers will compare the…
Sponsor: Biomedical Advanced Research and Development Authority • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can software make hospital pharmacists faster and safer?
Knowledge-focused CompletedThis study tests whether a software tool called Synapse Medicine can help hospital pharmacists who work with medical teams make better and faster medication recommendations. The tool analyzes each patient's health information to flag potential drug-related risks, such as harmful …
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Do unsuppressed HIV infections fuel new cases in ethiopia?
Knowledge-focused CompletedResearchers in Ethiopia are studying how HIV spreads among people with different treatment histories. They compare newly diagnosed individuals who have never taken antiretroviral therapy with those on therapy who have not achieved viral suppression, and with those who are virally…
Sponsor: Lund University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Scientists create controlled whooping cough infection to speed up vaccine research
Knowledge-focused CompletedThis completed phase 1 study tested whether giving healthy adults a controlled dose of whooping cough bacteria via nasal spray can safely cause mild infection. The goal was to establish a human infection model for future vaccine and treatment research. 79 participants aged 18-40 …
Phase 1 • Sponsor: Dalhousie University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a new polio vaccine stop the virus at the throat?
Knowledge-focused CompletedThis trial tests how well two polio vaccines protect the throat against poliovirus type-2. Healthy infants receive either bivalent oral polio vaccine (bOPV) or inactivated polio vaccine (IPV) in the first months of life. At 18 weeks, all infants get a dose of a newer oral polio v…
Phase 4 • Sponsor: Fidec Corporation • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Hospital staff TB screening under review: are routine tests necessary?
Knowledge-focused CompletedThis study looks back at records of over 1,000 new hospital workers in Nice, France, who were tested for latent (hidden) tuberculosis infection as part of their hiring process. The goal is to see how many test positive, what factors increase the risk, and whether the screening le…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Which Warm-Up wins: foam rolling or PNF stretching?
Knowledge-focused CompletedThis trial tests two common warm-up techniques in amateur athletes aged 18 to 30. After a short cycling warm-up, participants either roll their hamstrings with a foam roller or perform PNF stretching. Researchers measure hamstring flexibility, leg strength, vertical jump, and pai…
Sponsor: Acibadem University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
HPV infections in transgender people: a hidden health gap gets a closer look
Knowledge-focused CompletedThis observational study measures how often HPV infections and other sexually transmitted infections occur in transgender adults. Researchers will check for HPV at genital, anal, and oral sites, and also look for anal dysplasia, which can be a precursor to cancer. The study inclu…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Stomach acid drugs may skew h. pylori stool test results
Knowledge-focused CompletedThis study looks at whether taking common acid-reducing drugs (proton pump inhibitors, or PPIs) affects the accuracy of a stool DNA test for H. pylori, a stomach bacteria. Researchers will test 25 adults who need PPIs, first while on the drug and then after stopping it for 4 week…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists use clean ticks to sniff out hidden lyme infection
Knowledge-focused CompletedThis study tested whether clean, lab-bred ticks could find leftover Lyme bacteria in people who had been treated with antibiotics. 45 participants, including those with recent or past Lyme disease and healthy volunteers, had ticks placed on their skin for a few days. The goal was…
Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists probe Drug-Induced sunburn reactions
Knowledge-focused CompletedThis study looks at why some medications, like the antifungal voriconazole, can cause extreme sensitivity to sunlight, leading to severe sunburn-like reactions. Researchers will measure gene activity in skin samples from 62 participants, including healthy volunteers and patients …
Phase 1 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Ebola's hidden toll on Kids' brains revealed years later
Knowledge-focused CompletedThis study looked at children who survived Ebola and compared them to close contacts who never got sick. Researchers checked for brain, nerve, and thinking problems more than 5 years after infection. The goal was to understand what lasting issues survivors face, not to test a tre…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New document helps young adults voice End-of-Life wishes
Knowledge-focused CompletedThis study tested a document called Voicing My CHOiCES, designed to help young adults (ages 18-39) with serious illnesses like cancer or HIV discuss their care preferences. Participants filled out questionnaires about anxiety, social support, and communication, then reviewed the …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Which TB test works best for HIV patients? new study aims to find out
Knowledge-focused CompletedThis study looked at 200 people living with HIV in Liberia to compare two tests for latent tuberculosis (TB) infection: a blood test (IGRA) and a skin test (TST). The goal was to see which test works better in this population. Participants had a skin test and their results were c…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can mapping stress pathways help young people with HIV take better care of themselves?
Knowledge-focused CompletedThis study looks at how cumulative stress and trauma influence alcohol use and HIV self-management in young people living with HIV, ages 18 to 29. Researchers will track drinking patterns and viral load to identify modifiable targets for future interventions. The goal is to find …
Sponsor: Florida State University • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
COVID-19's hidden damage: new study scans heart, lungs, and brain
Knowledge-focused CompletedThis completed study looked at how COVID-19 affects the heart, lungs, brain, and kidneys in 202 people aged 18 to 80. Participants had imaging scans, blood tests, and other procedures to track inflammation and organ function over time. The goal was to understand why some people g…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Could a common acne pill weaken the nose's defense against COVID-19?
Knowledge-focused CompletedResearchers are asking whether isotretinoin, a drug used for severe acne, might increase the chance of catching COVID-19 or having a worse outcome. The drug can dry out the nasal lining, which may reduce the mucus and cilia that help trap viruses. The study compares about 148 peo…
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists compare sputum collection methods to improve diagnosis of lung infection
Knowledge-focused CompletedThis study looked at different ways to collect sputum (phlegm) from people with a lung infection called nontuberculous mycobacterial (NTM) infection. The goal was to see which method gives the best samples for diagnosing and understanding the infection. Participants provided thro…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
HIV drug side effects: new study probes liver damage risk
Knowledge-focused CompletedThis study looked at liver fibrosis (scarring) in 127 HIV patients who had high liver enzymes while on antiretroviral therapy. Participants underwent tests like liver biopsy, ultrasound, and CT scans to measure liver damage. The goal was to understand how common and severe liver …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
HPV treatments are unproven, but what do women want?
Knowledge-focused CompletedThis study interviews women aged 25 to 64 who have a high-risk HPV infection to learn what they value in potential treatments, such as cost, how the treatment is given, and how long it lasts. The researchers want to understand whether women consider unapproved treatments, what be…
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
AI analyzes texts to spot HIV risk in kenyan teens
Knowledge-focused CompletedThis completed study tested whether analyzing social media messages (like WhatsApp and Instagram) from 400 young women aged 18-24 in Kisumu, Kenya could help identify those at risk for HIV. Researchers used AI to look at language patterns and compared them to standard HIV risk sc…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can we better understand mpox in young people?
Knowledge-focused CompletedThis study gathers information from routine medical care on infants, children, and adolescents under 18 with confirmed mpox infection. Researchers aim to collect standardized data on symptoms, treatments, and outcomes to better understand how the disease affects young people. The…
Sponsor: PENTA Foundation • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can a global patient registry improve anal cancer care for people with HIV?
Knowledge-focused CompletedThis study builds a global registry of adults with anal squamous cell carcinoma, both with and without HIV infection. Researchers will collect real-world data on treatments, lab results, and outcomes to compare how the disease progresses in each group. The goal is to identify fac…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can a mouth rinse reveal hidden HPV risks in HIV patients?
Knowledge-focused CompletedThis study will check 300 people living with HIV for oral HPV infection and mouth lesions using a simple swish-and-spit sample. Researchers will compare those who test positive and negative, and look at factors like age, sex, tobacco use, and HIV lab results to see what might pre…
Sponsor: Vivent Health • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can a new test reveal the immune cells that beat hepatitis c?
Knowledge-focused CompletedThis study aims to develop a new laboratory technique to detect specific immune cells (called CD8 T cells) that target the hepatitis C virus (HCV). Researchers will use blood samples from people infected with HCV genotypes 1 or 4 to test and refine this technique. The goal is to …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can weekly tests pinpoint when STIs are truly gone?
Knowledge-focused CompletedThis study follows 140 adults who have been treated for uncomplicated chlamydia or gonorrhea infections. Participants will have weekly swabs or urine tests to check when the bacteria's genetic material (RNA) disappears from the body, up to 4 weeks after starting treatment. The go…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Gum disease clues: could hippo proteins be the missing link?
Knowledge-focused CompletedThis study investigates whether proteins from the Hippo signaling pathway—known to control cell growth and bone health—are present at different levels in the gum fluid of people with healthy gums, gingivitis, or periodontitis. Researchers will collect fluid samples from 75 partic…
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a new strategy break the cycle of HIV care dropout?
Knowledge-focused CompletedThis study aims to develop a program to help people living with HIV in Zambia re-engage with care after they have missed appointments or stopped taking their medication. Many people cycle in and out of HIV care, and returning is a critical moment to prevent future lapses. Researc…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
What did COVID-19 mean for family caregivers in zambia? a study seeks answers
Knowledge-focused CompletedThis study aims to understand the lived experiences of family caregivers who provide unpaid care to people with mental health conditions like depression, anxiety, and trauma in Zambia during the COVID-19 pandemic. Researchers will interview caregivers and mental health experts to…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can 'Good' cholesterol predict COVID-19 survival?
Knowledge-focused CompletedThis study looks at how lipoproteins, like HDL (good cholesterol) and LDL (bad cholesterol), change in patients with severe COVID-19 in the intensive care unit. Researchers will measure specific proteins on these particles to see if they can predict which patients are at higher r…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can High-Dose amoxicillin be made safer?
Knowledge-focused CompletedThis study looks at patients receiving high-dose intravenous amoxicillin for serious bacterial infections. Researchers will measure drug levels in the blood during the first week to see how much they vary between patients and within the same patient. They will also check for side…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can resilience defeat HIV stigma? a new study investigates
Knowledge-focused CompletedThis study looks at how psychological and social factors might help people living with HIV resist self-stigma—the negative feelings and beliefs they may hold about themselves due to their condition. Researchers will survey both patients and their healthcare providers to understan…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could knowing the germs behind summer diarrhea in kids lead to better prevention?
Knowledge-focused CompletedThis study aims to find out which germs cause summer diarrhea in children who visit the emergency room. Researchers will collect stool samples from children aged 0 to 16 and test them for viruses, bacteria, and parasites. The goal is to better understand the causes of these infec…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could a yellow tinge predict dangerous hospital infections?
Knowledge-focused CompletedThis study looks at whether jaundice, a yellowing of the skin and eyes, makes people with cirrhosis more likely to develop infections while in the hospital. Researchers will follow 250 Egyptian patients with cirrhosis to see if those with jaundice get more hospital-acquired infec…
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can company leaders help curb TB in High-Risk workplaces?
Knowledge-focused CompletedThis study surveys senior managers at companies in Zambia with silica dust exposure to assess their knowledge, attitudes, and practices regarding tuberculosis. Since these leaders shape workplace policies, their understanding is key to protecting workers. The findings could highl…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could leptospirosis leave lasting damage? a new study investigates
Knowledge-focused CompletedThis study looks at whether people who had leptospirosis, a bacterial infection spread by animals, may have health problems that last for years after the initial illness. Researchers in Reunion will follow about 200 patients who were previously hospitalized with the disease, chec…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could your gut bacteria shape your mood after cancer surgery?
Knowledge-focused CompletedThis study looks at whether having certain E. coli bacteria in the colon after colorectal cancer surgery is linked to anxiety or depression. Researchers will compare psychiatric symptoms and diagnoses between patients who carry the bacteria and those who do not. The goal is to be…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can a single HIV pill tame the epidemic in africa?
Knowledge-focused CompletedThis study follows about 1,000 adults in South Africa and Uganda who are switching to a common HIV treatment called TLD, which combines three drugs into one pill. The goal is to see how effective TLD is in everyday conditions, not just in controlled trials. If the treatment stops…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
COVID-19's hidden presence: could the virus lurk in sperm?
Knowledge-focused CompletedThis study looks at whether the virus that causes COVID-19 can be found in the semen of men with cancer who are storing sperm before treatment. Researchers will test both the fluid and the sperm cells for the virus and compare results with nasal swabs and blood tests. The goal is…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can smarter surveillance sharpen pneumonia vaccines?
Knowledge-focused CompletedThis study observes people in Belgium with non-invasive pneumococcal infections like pneumonia, ear infections, and sinusitis. Researchers will collect bacterial samples to see which strains are circulating and how they compare to invasive infections. The goal is to understand ho…
Sponsor: Sciensano • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can repeated weight loss and gain harm Athletes' metabolism?
Knowledge-focused CompletedThis study looks at how athletes who regularly lose and regain weight to meet competition categories experience changes in metabolism, body temperature, and body composition. Researchers will track 48 athletes through periods of weight maintenance, loss, and regain, using body te…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
A closer look at the scalp: could trichoscopy predict fungal cure?
Knowledge-focused CompletedThis observational study in children and adolescents with tinea capitis (a scalp fungal infection) investigates whether changes seen under a trichoscope—a special microscope for hair and scalp—can predict when the infection is cured. Participants receive the antifungal drug terbi…
Sponsor: Istanbul Medeniyet University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Could hepatitis e be hiding in transplant patients? a screening study aims to find out.
Knowledge-focused CompletedHepatitis E can cause severe liver problems in people who have had an organ transplant, and may become chronic. This study screens liver and kidney transplant patients in Guadeloupe using blood tests to measure how many carry the virus. The goal is to learn whether routine screen…
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
Knowledge-focused CompletedThis trial looks at whether giving the antibiotic ertapenem as a shot under the skin works as well as giving it through a vein in people aged 75 and older who have infections. Many older patients have poor veins or behavioral issues that make IV access difficult. The study will m…
Phase 4 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Are adults in beijing still protected against tetanus? a study investigates
Knowledge-focused CompletedThis observational study aims to measure tetanus antibody levels in healthy adults living in Beijing, China. Researchers will analyze how antibody protection varies across different age groups and whether vaccination history predicts current immunity. Participants provide a singl…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can COVID-19 and emergency surgery be safely managed together? a massive hospital study seeks answers
Knowledge-focused CompletedThis study looks at how COVID-19 and acute surgical conditions (like appendicitis or internal bleeding) affect each other in hospitalized adults. Researchers will analyze real-world data from a large hospital to understand treatment outcomes and develop models to predict in-hospi…
Sponsor: Pirogov Russian National Research Medical University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Blood test clues could make antifungal dosing safer for transplant patients
Knowledge-focused CompletedThis study looks back at medical records of transplant recipients (lung, kidney, liver, or bone marrow) who received the antifungal drug isavuconazole. Researchers want to understand why blood levels of the drug vary so much between patients and whether higher levels are linked t…
Sponsor: Zhibin Xu • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Could sharing your HIV status help you stick to medication?
Knowledge-focused CompletedThis study investigates whether telling others about an HIV diagnosis affects how consistently people take their HIV medications. Researchers believe that disclosure might lead to social support, which could improve adherence. The study follows 120 people with HIV who are already…
Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Gene expression platform could revolutionize kidney transplant rejection diagnosis
Knowledge-focused CompletedThis study developed and tested HistoMX, an automated platform that analyzes gene activity in kidney transplant biopsy samples. Researchers used over 2,400 archived biopsies from adult kidney transplant recipients to see if the platform could accurately identify different types o…
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Why COVID-19 lungs fail: tiny blood vessel damage may be key
Knowledge-focused CompletedThis study investigates why COVID-19 causes severe lung injury (ARDS) by looking at tiny blood vessels in the lungs. Researchers will compare 39 patients with COVID-19 ARDS to those with ARDS from other causes. They measure 'alveolar dead space' — lung areas that get air but not …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
Knowledge-focused CompletedThis study looks at whether simple, non-invasive blood test scores can predict the risk of developing liver cancer in people with advanced liver disease who have been cured of hepatitis C. Researchers analyzed data from 571 adults treated at a single hospital over ten years. The …
Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Large UK study tracks COVID-19's toll on MS patients
Knowledge-focused CompletedThis study follows thousands of people with multiple sclerosis (MS) in the UK to see how COVID-19 affects them. Researchers track infections, hospital stays, and deaths using questionnaires and national health data. The goal is to understand the risks and outcomes for this group,…
Sponsor: Swansea University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Malaria's next threat: drug-resistant parasites spread even after treatment
Knowledge-focused CompletedThis study looked at whether malaria parasites that are resistant to artemisinin drugs spread more easily after standard treatment. Researchers treated 160 people in Uganda who had malaria with either artemether-lumefantrine or dihydroartemisinin-piperaquine. They then used mosqu…
Phase 4 • Sponsor: Infectious Diseases Research Collaboration, Uganda • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Scientists probe why lung disease raises COVID-19 risk
Knowledge-focused CompletedThis study investigates how the immune system responds to COVID-19 in people with chronic lung conditions like asthma, COPD, or cystic fibrosis, compared to those without lung disease. Researchers collect blood, sputum, and nasal samples to measure immune signals and gene activit…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could an eye exam reveal hidden brain damage in HIV patients?
Knowledge-focused CompletedThis study looks at cerebral small vessel disease (CSVD) — damage to tiny blood vessels in the brain that can cause memory loss and disability — in people with HIV over age 50. Researchers want to see if CSVD is linked to blood vessel problems in the eyes and kidneys, which could…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
French study tracks COVID-19's toll on pregnant women and their babies
Knowledge-focused CompletedThis study follows thousands of pregnant women in France who had or likely had COVID-19 during pregnancy or shortly after giving birth. Researchers track health problems in both mothers and newborns up to 12 weeks after delivery, using medical records and questionnaires about men…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
One-year survival and recovery in elderly COVID-19 patients under scrutiny
Knowledge-focused CompletedThis study follows people aged 70 and older who were hospitalized with severe COVID-19 for one year after their diagnosis. Researchers aim to describe how many survive and how well they recover, including physical and mental function. The goal is to better understand the long-ter…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tracking superbugs from mother to baby: a chicago study
Knowledge-focused CompletedThis study looks at how drug-resistant bacteria, specifically ESBL-producing E. coli, are passed from mothers to their newborns during vaginal birth or scheduled C-sections. Researchers will test stool samples from 200 healthy mothers and their babies at a Chicago hospital to see…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Hidden danger: study probes blood clot risk in cancer patients with COVID-19
Knowledge-focused CompletedThis study investigates how often cancer patients with COVID-19 develop dangerous blood clots (venous thromboembolism). Researchers will screen participants using ultrasound and blood tests to detect clots, whether or not they cause symptoms. The goal is to understand the true ra…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Rare botulism cases reviewed to improve ICU care
Knowledge-focused CompletedThis study reviews the medical records of people who were hospitalized in French intensive care units (ICUs) for severe botulism poisoning. Botulism is a rare but serious illness caused by a toxin that can paralyze muscles. The goal is to describe what happened to these patients,…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could your workout change the germs in your mouth?
Knowledge-focused CompletedThis study looks at how different amounts of endurance exercise—from none to high levels—affect the bacteria living in the mouth of young adults aged 18 to 30. Researchers will collect saliva and gum samples to compare the oral microbiome and signs of inflammation. The goal is to…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Nose drops of pneumonia bacteria could pave way for better vaccines
Knowledge-focused CompletedThis study investigates how a specific strain of pneumococcus bacteria (serotype 3) colonizes the nose of healthy adults. Researchers will give volunteers nose drops containing the bacteria to see what dose leads to colonization and how long the bacteria stay before the immune sy…
Sponsor: Liverpool School of Tropical Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI predicts dental numbing success in painful tooth condition
Knowledge-focused CompletedThis study looks at whether computer models can predict if local anesthetic (numbing) will work for people with a painful tooth condition called symptomatic irreversible pulpitis. Researchers analyzed records from 4,390 adult patients to compare three different machine learning a…
Sponsor: Jamia Millia Islamia • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Pandemic's hidden toll: study reveals emotional strain on hospital staff
Knowledge-focused CompletedThis study looked at the emotional well-being of healthcare workers treating COVID-19 patients at two French hospitals. 78 staff members completed questionnaires about anxiety, depression, resilience, and empathy at different times during the pandemic. The goal was to understand …
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
French hospital staff antibody study reveals infection patterns
Knowledge-focused CompletedThis study tested over 1,500 hospital workers in four French hospitals for COVID-19 antibodies to see how many had been infected. Researchers compared infection rates among staff in COVID-19 units, other care areas, and non-care roles, and across regions with different outbreak i…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
COVID outpatients tracked for two years in simple mail study
Knowledge-focused CompletedThis study followed 92 people who had mild COVID and were treated at home. Two years after their diagnosis, they answered a questionnaire by mail about any hospital visits or other health events. The goal was to learn how outpatients fare over time and find patterns that could he…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Enzyme-HPV link in cervical disease explored
Knowledge-focused CompletedThis study looked at how certain enzymes called matrix metalloproteinases (MMPs) and their inhibitors relate to human papillomavirus (HPV) in cervical dysplasia and cancer. Researchers collected tissue and cell samples from 216 women with different stages of cervical lesions. The…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Researchers hunt for clues to predict deadly pancreas infection
Knowledge-focused CompletedThis study reviewed medical records of 148 adults admitted to the ICU with severe acute pancreatitis. The goal was to find risk factors for infected pancreatic necrosis, a serious complication that raises the risk of death. By identifying these factors, doctors hope to diagnose a…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Study links NSAIDs to severe bacterial infections
Knowledge-focused CompletedThis study looked at 335 adults hospitalized with bacterial infections to see if taking NSAIDs (like ibuprofen) before admission made their infections more severe. Researchers compared those with complicated infections (abscesses, needing surgery) to those with simpler infections…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Study tracks pneumococcal infections in adults to sharpen vaccine strategies
Knowledge-focused CompletedThis completed study monitored 1560 adults hospitalized with invasive pneumococcal infections (excluding meningitis) across France. Researchers collected information on infection severity, risk factors, and bacterial serotypes to understand how these infections occur and how vacc…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can a simple blood test spot who will die from H1N1?
Knowledge-focused CompletedThis study measured levels of mannose-binding lectin (MBL), a protein involved in immune response, in 97 ICU patients with severe H1N1-related acute respiratory distress syndrome (ARDS). Researchers wanted to see if higher or lower MBL levels were linked to a higher risk of death…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
PET scans reveal hidden brain changes in young COVID survivors
Knowledge-focused CompletedThis completed study looked at 25 young adults (ages 18-65) who had severe COVID-19 and now have thinking or memory problems. Researchers used a special PET-CT scan to see if there are changes in brain activity and how that relates to lung damage. The goal was to better understan…
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can Peer-Led lessons help students learn about STIs? new study tests two approaches
Knowledge-focused CompletedThis study tested two peer education programs to see which better improves nursing students' knowledge, attitudes, and behaviors about sexually transmitted infections (STIs). Thirty-six first-year nursing students were split into two groups: one received a program based on a beha…
Sponsor: Sakarya University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New algorithm may simplify heart checks in septic shock patients
Knowledge-focused CompletedThis study tested whether simpler ultrasound measurements can accurately predict left ventricular function in patients with septic shock. Researchers enrolled 80 patients and compared standard heart function tests (LVEF and GLS) with easier-to-collect parameters like mitral annul…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Pre-Transplant blood test may flag BK virus danger
Knowledge-focused CompletedThis completed study looked at 378 kidney transplant patients to see if measuring antibodies against BK virus before transplant could predict whether the virus would reactivate after surgery. Researchers used a lab-made virus-like particle to test for five different BK virus type…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
PET scans outshine older method for rare ear infection?
Knowledge-focused CompletedThis study compared two imaging methods—PET/CT and labeled leukocyte scintigraphy—for monitoring malignant otitis externa, a serious infection of the ear canal that can spread to the skull. Researchers looked at 18 patients who had both scans before and after antibiotic treatment…
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
RSV shot uptake under the microscope: how many german babies get protected?
Knowledge-focused CompletedThis study tracks how many infants in Germany receive nirsevimab, a long-acting antibody that helps protect against severe RSV disease. Researchers will survey parents of babies born during three RSV seasons (2024–2027) to measure immunization rates. The goal is to see how well t…
Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can HIIT or moderate exercise improve sleep for people with HIV?
Knowledge-focused CompletedThis study looked at how two types of exercise—high-intensity interval training (HIIT) and continuous moderate exercise—affect sleep and inflammation in 52 older adults with HIV. Participants exercised three times a week for 16 weeks. Researchers measured sleep quality through su…
Sponsor: Christine Horvat Davey • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Hepatitis c study tests whether a patient registry is possible in vietnam
Knowledge-focused CompletedThis study looked at whether it's possible to create a group of people with hepatitis C in Hai Phong, Vietnam, for future research. 300 adults with active hepatitis C took part. The goal was to see how many patients could be enrolled and how much information could be collected, n…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Pedal power: strength training boosts cyclist performance, but gains fade
Knowledge-focused CompletedThis study looked at whether adding strength training to regular cycling workouts helps competitive cyclists improve performance and muscle function. Twenty-four male cyclists either did strength training plus endurance training or just endurance training for 10 weeks. Researcher…
Sponsor: Lithuanian Sports University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Simple bedside check may predict who needs emergency treatment for sepsis
Knowledge-focused CompletedThis study looked at 526 adults with sepsis who had normal blood pressure to see if a simple measure called the diastolic shock index (DSI) and a blood test for lactate could predict which patients would need medication to support their blood pressure within 6 hours. Researchers …
Sponsor: Hospital H+ Queretaro • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
UTI superbugs: study reveals resistance patterns in uganda
Knowledge-focused CompletedThis completed study looked at antibiotic resistance in bacteria causing urinary tract infections (UTIs) in Uganda. Researchers compared resistance patterns in patients who sought care at community drug shops versus hospitals. By studying 890 participants, they aim to understand …
Sponsor: St George's, University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to help detect sepsis in newborns faster
Knowledge-focused CompletedThis study looked at 58 full-term newborns with suspected early-onset sepsis to find early clinical signs that could help doctors tell if a bacterial infection is present. Researchers reviewed medical records from 2013 at a single hospital. The goal was to improve diagnosis and a…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Ultrasound patch could help ER doctors spot sepsis patients needing ICU care
Knowledge-focused CompletedThis study tested whether a small ultrasound patch called FloPatch can help emergency doctors predict which sepsis patients will need intensive care. The device measures how well the heart responds to fluids. Researchers followed 134 patients to see if FloPatch readings could pre…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hepatitis b mutations linked to higher virus levels
Knowledge-focused CompletedThis study looks at how certain genetic changes (mutations) in the hepatitis B virus (HBV) affect the amount of virus in the blood of people with chronic infection. Researchers analyzed blood samples from 92 patients not on antiviral treatment. They found that specific mutations …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ICU antibiotics under scrutiny: new study targets hidden brain risks
Knowledge-focused CompletedThis study followed 400 intensive care patients receiving beta-lactam antibiotics to see how often these drugs cause brain-related side effects like confusion or agitation. Researchers measured antibiotic levels in the blood and checked patients' neurological status several times…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can ultrasound help doctors give the right amount of fluids in septic shock?
Knowledge-focused CompletedThis study tested whether a specific ultrasound-based algorithm could help doctors better manage fluids in patients with septic shock. The trial involved 136 intensive care patients and compared the algorithm to standard care over the first 4 days. The goal was to see if the algo…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Train transfers for COVID ICU patients: did it work?
Knowledge-focused CompletedThis study looked at 37 critically ill COVID-19 patients who were moved by train from overcrowded ICUs in Paris to less busy ICUs in western France. Researchers tracked how many died, got infections, needed breathing machines, and how long they stayed in the hospital. The goal wa…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
ECMO studied in 761 severe COVID-19 patients: does it help?
Knowledge-focused CompletedThis study looked at whether ECMO, a machine that does the work of the heart and lungs, helps people with severe COVID-19 who have lung failure or heart failure. Researchers tracked 761 patients across France to see how many survived and how quickly they recovered. The goal was t…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
COVID-19's hidden toll on the brain revealed by MRI
Knowledge-focused CompletedThis study looked at 21 adults with COVID-19 who had neurological symptoms like loss of smell, headache, or memory problems. Researchers used MRI scans to find brain changes linked to the virus. The goal was to better understand how COVID-19 can affect the brain, not to test a tr…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Pandemic's hidden toll: study screens new mothers for postpartum depression
Knowledge-focused CompletedThis study screens women who gave birth in four French hospitals for postpartum depression and anxiety during the COVID-19 pandemic. Participants fill out three questionnaires shortly after delivery and again about a month later. The goal is to measure how common postpartum depre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
ECMO Patients' antibiotic levels under the microscope
Knowledge-focused CompletedThis study looked at how the body processes an antibiotic called piperacillin in intensive care patients who are on a life-support machine (ECMO) compared to those who are not. Researchers wanted to see if ECMO changes antibiotic levels, which could affect how well the drug fight…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Hidden immune fire: could CMV or autoimmunity be fueling HIV-Related inflammation?
Knowledge-focused CompletedThis study looks at why certain immune cells (CD4 and CD8 T cells) remain activated in people with HIV whose viral load has been undetectable on antiretroviral therapy for at least two years. Researchers are investigating whether a common virus called cytomegalovirus (CMV) or an …
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Rheumatism Patients' COVID antibodies under the microscope
Knowledge-focused CompletedThis study followed 163 people with chronic inflammatory rheumatism (like rheumatoid arthritis) who had a recent COVID-19 infection. Researchers measured their antibody levels over two years to see how immunosuppressive drugs affect antibody persistence. The goal was to better un…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Zambia study tracks hepatitis b outcomes in hundreds of patients
Knowledge-focused CompletedThis study followed 326 adults in Zambia with chronic hepatitis B for up to 5 years. Researchers tracked how the virus behaves, how many patients need treatment, and how many develop serious liver problems like cirrhosis or liver cancer. The goal was to better understand the dise…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New blood marker may help spot deadliest sepsis cases
Knowledge-focused CompletedThis study looked at whether measuring hepcidin, a hormone that controls iron levels, in the blood of 114 patients with severe sepsis or septic shock could predict who would die within 28 days. Researchers also tracked deaths at 90 days and infections acquired in the hospital. Th…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Cancer patients face more treatment side effects from rare lung infections
Knowledge-focused CompletedThis study examined 41 patients treated for non-tuberculous mycobacteria (NTM) infections, comparing those with and without cancer. The goal was to count side effects from NTM treatment in each group to understand why cancer patients often stop therapy. Researchers hope this will…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
HIV Patients' thyroid health under the microscope
Knowledge-focused CompletedThis study looked at how often thyroid problems (specifically an underactive thyroid) occur in people with HIV. Researchers reviewed medical records of 154 HIV-positive adults who were treated at a French hospital between 2001 and 2012. The goal was to get a clearer picture of th…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Meth reduction may lower STI risk, small study suggests
Knowledge-focused CompletedThis completed study looked at 59 men who have sex with men and use methamphetamine. Researchers used a program that gives rewards for drug-free urine samples to help them cut back. They measured inflammation in the rectum and tracked STI/HIV risk behaviors over 8 weeks. The goal…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
TB drug dosing under the microscope: could standard doses be off?
Knowledge-focused CompletedThis study examined whether the standard dose of isoniazid, a key tuberculosis drug, is right for all adults. Researchers measured drug levels in 112 patients to see if some were getting too much or too little. The goal was to understand how individual differences in drug process…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Pandemic stress hits hard for arthritis patients
Knowledge-focused CompletedThis completed study looked at how the COVID-19 pandemic and social distancing impacted the mental health of 259 adults with chronic inflammatory rheumatism (like rheumatoid arthritis or ankylosing spondylitis). Researchers used questionnaires to measure stress, depression, anxie…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Which COVID-19 shot causes fewer side effects? new study compares novavax and pfizer
Knowledge-focused CompletedThis completed study looked at how often healthcare workers and first responders experienced short-term side effects (like fever or sore arm) after getting either the updated Novavax or Pfizer COVID-19 vaccine. About 660 adults who had at least one prior COVID-19 shot took part. …
Phase 4 • Sponsor: Novavax • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC